trougakos i - Search Results

Year	Number of Results
1997	1
1998	2
1999	1
2001	2
2002	3
2003	2
2004	5
2005	3
2006	6
2007	4
2008	2
2009	5
2010	2
2011	6
2012	1
2013	10
2014	2
2015	6
2016	5
2017	9
2018	13
2019	21
2020	12
2021	45
2022	33
2023	14
2024	2

1

Implications and hidden toxicity of cardiometabolic syndrome and early-stage heart failure in carfilzomib-induced cardiotoxicity.

Efentakis P, Varela A, Lamprou S, Papanagnou ED, Chatzistefanou M, Christodoulou A, Davos CH, Gavriatopoulou M, Trougakos I, Dimopoulos MA, Terpos E, Andreadou I. Efentakis P, et al. Among authors: trougakos i. Br J Pharmacol. 2024 Apr 28. doi: 10.1111/bph.16391. Online ahead of print. Br J Pharmacol. 2024. PMID: 38679957

2

Biomarkers of NRF2 signalling: Current status and future challenges.

Morgenstern C, Lastres-Becker I, Demirdöğen BC, Costa VM, Daiber A, Foresti R, Motterlini R, Kalyoncu S, Arioz BI, Genc S, Jakubowska M, Trougakos IP, Piechota-Polanczyk A, Mickael M, Santos M, Kensler TW, Cuadrado A, Copple IM. Morgenstern C, et al. Among authors: trougakos ip. Redox Biol. 2024 Jun;72:103134. doi: 10.1016/j.redox.2024.103134. Epub 2024 Mar 30. Redox Biol. 2024. PMID: 38643749 Free PMC article. Review.

3

Rapid transient and longer-lasting innate cytokine changes associated with adaptive immunity after repeated SARS-CoV-2 BNT162b2 mRNA vaccinations.

Rosati M, Terpos E, Homan P, Bergamaschi C, Karaliota S, Ntanasis-Stathopoulos I, Devasundaram S, Bear J, Burns R, Bagratuni T, Trougakos IP, Dimopoulos MA, Pavlakis GN, Felber BK. Rosati M, et al. Among authors: trougakos ip. Front Immunol. 2023 Nov 27;14:1292568. doi: 10.3389/fimmu.2023.1292568. eCollection 2023. Front Immunol. 2023. PMID: 38090597 Free PMC article.

4

Longitudinal Analysis of Antibody Response Following SARS-CoV-2 Infection Depending on Disease Severity: A Prospective Cohort Study.

Zirou C, Gumeni S, Bellos I, Ntanasis-Stathopoulos I, Sklirou AD, Bagratuni T, Korompoki E, Apostolakou F, Papassotiriou I, Trougakos IP, Terpos E. Zirou C, et al. Among authors: trougakos ip. Viruses. 2023 Nov 13;15(11):2250. doi: 10.3390/v15112250. Viruses. 2023. PMID: 38005927 Free PMC article.

5

Sustained Nrf2 Overexpression-Induced Metabolic Deregulation Can Be Attenuated by Modulating Insulin/Insulin-like Growth Factor Signaling.

Gumeni S, Lamprou M, Evangelakou Z, Manola MS, Trougakos IP. Gumeni S, et al. Among authors: trougakos ip. Cells. 2023 Nov 18;12(22):2650. doi: 10.3390/cells12222650. Cells. 2023. PMID: 37998385 Free PMC article.

6

Boosting autophagy in anti-tumor proteasome inhibition-mediated cardiotoxicity.

Papanagnou ED, Gumeni S, Trougakos IP. Papanagnou ED, et al. Among authors: trougakos ip. Aging (Albany NY). 2023 May 8;15(9):3226-3227. doi: 10.18632/aging.204724. Epub 2023 May 8. Aging (Albany NY). 2023. PMID: 37166427 Free PMC article. No abstract available.

7

Loss of Kmt2c in vivo leads to EMT, mitochondrial dysfunction and improved response to lapatinib in breast cancer.

Simigdala N, Chalari A, Sklirou AD, Chavdoula E, Papafotiou G, Melissa P, Kafalidou A, Paschalidis N, Pateras IS, Athanasiadis E, Konstantopoulos D, Trougakos IP, Klinakis A. Simigdala N, et al. Among authors: trougakos ip. Cell Mol Life Sci. 2023 Mar 18;80(4):100. doi: 10.1007/s00018-023-04734-7. Cell Mol Life Sci. 2023. PMID: 36933062 Free PMC article.

8

Cardiovascular Toxicity of Proteasome Inhibitors: Underlying Mechanisms and Management Strategies: JACC: CardioOncology State-of-the-Art Review.

Georgiopoulos G, Makris N, Laina A, Theodorakakou F, Briasoulis A, Trougakos IP, Dimopoulos MA, Kastritis E, Stamatelopoulos K. Georgiopoulos G, et al. Among authors: trougakos ip. JACC CardioOncol. 2023 Feb 21;5(1):1-21. doi: 10.1016/j.jaccao.2022.12.005. eCollection 2023 Feb. JACC CardioOncol. 2023. PMID: 36875897 Free PMC article. Review.

9

Short term starvation potentiates the efficacy of chemotherapy in triple negative breast cancer via metabolic reprogramming.

Pateras IS, Williams C, Gianniou DD, Margetis AT, Avgeris M, Rousakis P, Legaki AI, Mirtschink P, Zhang W, Panoutsopoulou K, Delis AD, Pagakis SN, Tang W, Ambs S, Warpman Berglund U, Helleday T, Varvarigou A, Chatzigeorgiou A, Nordström A, Tsitsilonis OE, Trougakos IP, Gilthorpe JD, Frisan T. Pateras IS, et al. Among authors: trougakos ip. J Transl Med. 2023 Mar 3;21(1):169. doi: 10.1186/s12967-023-03935-9. J Transl Med. 2023. PMID: 36869333 Free PMC article.

10

XBB.1.5 neutralizing antibodies upon bivalent COVID-19 vaccination are similar to XBB but lower than BQ.1.1.

Devasundaram S, Terpos E, Rosati M, Ntanasis-Stathopoulos I, Bear J, Burns R, Skourti S, Malandrakis P, Trougakos IP, Dimopoulos MA, Pavlakis GN, Felber BK. Devasundaram S, et al. Among authors: trougakos ip. Am J Hematol. 2023 May;98(5):E123-E126. doi: 10.1002/ajh.26887. Epub 2023 Mar 7. Am J Hematol. 2023. PMID: 36810791 Free PMC article. No abstract available.

11

Evaluation of the Small Heat Shock Protein Family Members HSPB2 and HSPB3 in Bladder Cancer Prognosis and Progression.

Gianniou DD, Sklirou AD, Papadimitriou MA, Pilala KM, Stravodimos K, Avgeris M, Scorilas A, Trougakos IP. Gianniou DD, et al. Among authors: trougakos ip. Int J Mol Sci. 2023 Jan 30;24(3):2609. doi: 10.3390/ijms24032609. Int J Mol Sci. 2023. PMID: 36768927 Free PMC article.

12

Serological testing for SARS-CoV-2: Advancements and future challenges.

Alexopoulos H, Trougakos IP, Dimopoulos MA, Terpos E. Alexopoulos H, et al. Among authors: trougakos ip. Eur J Intern Med. 2023 Feb;108:104-105. doi: 10.1016/j.ejim.2022.12.023. Epub 2022 Dec 27. Eur J Intern Med. 2023. PMID: 36586739 Free PMC article. No abstract available.

13

Clinical usefulness of testing for severe acute respiratory syndrome coronavirus 2 antibodies.

Alexopoulos H, Trougakos IP, Dimopoulos MA, Terpos E. Alexopoulos H, et al. Among authors: trougakos ip. Eur J Intern Med. 2023 Jan;107:7-16. doi: 10.1016/j.ejim.2022.11.009. Epub 2022 Nov 10. Eur J Intern Med. 2023. PMID: 36379820 Free PMC article. Review.

14

COVID-19 BNT162b2 mRNA vaccine for patients with type 2 diabetes mellitus.

Paschou SA, Karalis V, Psaltopoulou T, Charitaki I, Sklirou AD, Iconomidou VA, Vasileiou V, Kassi GN, Vryonidou A, Kokkinos A, Tentolouris N, Hatziaggelaki E, Trougakos IP, Terpos E, Dimopoulos MA. Paschou SA, et al. Among authors: trougakos ip. Hormones (Athens). 2023 Mar;22(1):17-18. doi: 10.1007/s42000-022-00419-1. Epub 2022 Nov 11. Hormones (Athens). 2023. PMID: 36369623 Free PMC article. No abstract available.

15

Patients with type 2 diabetes mellitus present similar immunological response to COVID-19 BNT162b2 mRNA vaccine to healthy subjects: a prospective cohort study.

Paschou SA, Karalis V, Psaltopoulou T, Charitaki I, Sklirou AD, Iconomidou VA, Vasileiou V, Kassi GN, Vryonidou A, Kokkinos A, Tentolouris N, Hatziaggelaki E, Trougakos IP, Terpos E, Dimopoulos MA. Paschou SA, et al. Among authors: trougakos ip. Hormones (Athens). 2023 Mar;22(1):5-11. doi: 10.1007/s42000-022-00405-7. Epub 2022 Oct 21. Hormones (Athens). 2023. PMID: 36269544 Free PMC article.

16

Autophagy activation can partially rescue proteasome dysfunction-mediated cardiac toxicity.

Papanagnou ED, Gumeni S, Sklirou AD, Rafeletou A, Terpos E, Keklikoglou K, Kastritis E, Stamatelopoulos K, Sykiotis GP, Dimopoulos MA, Trougakos IP. Papanagnou ED, et al. Among authors: trougakos ip. Aging Cell. 2022 Nov;21(11):e13715. doi: 10.1111/acel.13715. Epub 2022 Oct 19. Aging Cell. 2022. PMID: 36259256 Free PMC article.

17

Assessment of Postvaccination Neutralizing Antibodies Response against SARS-CoV-2 in Cancer Patients under Treatment with Targeted Agents.

Zagouri F, Papatheodoridi A, Liontos M, Briasoulis A, Sklirou AD, Skafida E, Fiste O, Markellos C, Andrikopoulou A, Koutsoukos K, Kaparelou M, Gkogkou E, Trougakos IP, Dimopoulos MA, Terpos E. Zagouri F, et al. Among authors: trougakos ip. Vaccines (Basel). 2022 Sep 5;10(9):1474. doi: 10.3390/vaccines10091474. Vaccines (Basel). 2022. PMID: 36146552 Free PMC article.

18

COVID-19 mRNA vaccine-induced adverse effects: unwinding the unknowns.

Trougakos IP, Terpos E, Alexopoulos H, Politou M, Paraskevis D, Scorilas A, Kastritis E, Andreakos E, Dimopoulos MA. Trougakos IP, et al. Trends Mol Med. 2022 Oct;28(10):800-802. doi: 10.1016/j.molmed.2022.07.008. Epub 2022 Sep 12. Trends Mol Med. 2022. PMID: 36114090 Free PMC article. No abstract available.

19

High mRNA Expression Levels of Heat Shock Protein Family B Member 2 (HSPB2) Are Associated with Breast Cancer Patients' Relapse and Poor Survival.

Sklirou AD, Gianniou DD, Karousi P, Cheimonidi C, Papachristopoulou G, Kontos CK, Scorilas A, Trougakos IP. Sklirou AD, et al. Among authors: trougakos ip. Int J Mol Sci. 2022 Aug 28;23(17):9758. doi: 10.3390/ijms23179758. Int J Mol Sci. 2022. PMID: 36077156 Free PMC article.

20

Development of Stilbenoid and Chalconoid Analogues as Potent Tyrosinase Modulators and Antioxidant Agents.

Vontzalidou A, Dimitrakoudi SM, Tsoukalas K, Zoidis G, Chaita E, Dina E, Cheimonidi C, Trougakos IP, Lambrinidis G, Skaltsounis AL, Mikros E, Aligiannis N. Vontzalidou A, et al. Among authors: trougakos ip. Antioxidants (Basel). 2022 Aug 17;11(8):1593. doi: 10.3390/antiox11081593. Antioxidants (Basel). 2022. PMID: 36009312 Free PMC article.

21

Cardiac mechanics in response to proteasome inhibition: a prospective study.

Makris N, Georgiopoulos G, Laina A, Tselegkidi ME, Fotiou D, Kanellias N, Eleftherakis-Papaiakovou E, Migkou M, Papanagnou ED, Katogiannis K, Petropoulos I, Anninos H, Bampatsias D, Maneta E, Samouilidou E, Nikas D, Ciliberti G, Stellos K, Terpos E, Gavriatopoulou M, Trougakos IP, Ikonomidis I, Dimopoulos MA, Kastritis E, Stamatelopoulos K. Makris N, et al. Among authors: trougakos ip. Eur Heart J Cardiovasc Imaging. 2023 Apr 24;24(5):643-652. doi: 10.1093/ehjci/jeac168. Eur Heart J Cardiovasc Imaging. 2023. PMID: 35980754

22

Second Booster BNT162b2 Restores SARS-CoV-2 Humoral Response in Patients With Multiple Myeloma, Excluding Those Under Anti-BCMA Therapy.

Ntanasis-Stathopoulos I, Karalis V, Gavriatopoulou M, Malandrakis P, Sklirou AD, Eleutherakis-Papaiakovou E, Migkou M, Roussou M, Fotiou D, Alexopoulos H, Theodorakakou F, Kastritis E, Iconomidou VA, Trougakos IP, Dimopoulos MA, Terpos E. Ntanasis-Stathopoulos I, et al. Among authors: trougakos ip. Hemasphere. 2022 Jul 29;6(8):e764. doi: 10.1097/HS9.0000000000000764. eCollection 2022 Aug. Hemasphere. 2022. PMID: 35928542 Free PMC article.

23

SARS-CoV-2 humoral responses following booster BNT162b2 vaccination in patients with B-cell malignancies.

Terpos E, Fotiou D, Karalis V, Ntanasis-Stathopoulos I, Sklirou AD, Gavriatopoulou M, Malandrakis P, Iconomidou VA, Kastritis E, Trougakos IP, Dimopoulos MA. Terpos E, et al. Among authors: trougakos ip. Am J Hematol. 2022 Oct;97(10):1300-1308. doi: 10.1002/ajh.26669. Epub 2022 Aug 2. Am J Hematol. 2022. PMID: 35871310 Free PMC article.

24

Third Dose of the BNT162b2 Vaccine Results in Sustained High Levels of Neutralizing Antibodies Against SARS-CoV-2 at 6 Months Following Vaccination in Healthy Individuals.

Ntanasis-Stathopoulos I, Karalis V, Sklirou AD, Gavriatopoulou M, Alexopoulos H, Malandrakis P, Trougakos IP, Dimopoulos MA, Terpos E. Ntanasis-Stathopoulos I, et al. Among authors: trougakos ip. Hemasphere. 2022 Jun 21;6(7):e747. doi: 10.1097/HS9.0000000000000747. eCollection 2022 Jul. Hemasphere. 2022. PMID: 35813098 Free PMC article. No abstract available.

25

Isolation of an Extract from the Soft Coral Symbiotic Microorganism Salinispora arenicola Exerting Cytoprotective and Anti-Aging Effects.

Louka XP, Sklirou AD, Le Goff G, Lopes P, Papanagnou ED, Manola MS, Benayahu Y, Ouazzani J, Trougakos IP. Louka XP, et al. Among authors: trougakos ip. Curr Issues Mol Biol. 2021 Dec 22;44(1):14-30. doi: 10.3390/cimb44010002. Curr Issues Mol Biol. 2021. PMID: 35723381 Free PMC article.

26

Determining patterns of vascular function and structure in wild-type transthyretin cardiac amyloidosis. A comparative study.

Stamatelopoulos K, Delialis D, Georgiopoulos G, Tselegkidi MI, Theodorakakou F, Dialoupi I, Bambatsias D, Petropoulos I, Vergaro G, Ikonomidis I, Tzortzis S, Briasoulis A, Kanakakis J, Trougakos I, Dimopoulos MA, Kastritis E. Stamatelopoulos K, et al. Among authors: trougakos i. Int J Cardiol. 2022 Sep 15;363:102-110. doi: 10.1016/j.ijcard.2022.06.035. Epub 2022 Jun 16. Int J Cardiol. 2022. PMID: 35716935

27

SARS-CoV-2 Neutralizing Antibodies Kinetics Postvaccination in Cancer Patients under Treatment with Immune Checkpoint Inhibition.

Terpos E, Liontos M, Fiste O, Zagouri F, Briasoulis A, Sklirou AD, Markellos C, Skafida E, Papatheodoridi A, Andrikopoulou A, Koutsoukos K, Kaparelou M, Iconomidou VA, Trougakos IP, Dimopoulos MA. Terpos E, et al. Among authors: trougakos ip. Cancers (Basel). 2022 Jun 4;14(11):2796. doi: 10.3390/cancers14112796. Cancers (Basel). 2022. PMID: 35681774 Free PMC article.

28

Adverse effects of COVID-19 mRNA vaccines: the spike hypothesis.

Trougakos IP, Terpos E, Alexopoulos H, Politou M, Paraskevis D, Scorilas A, Kastritis E, Andreakos E, Dimopoulos MA. Trougakos IP, et al. Trends Mol Med. 2022 Jul;28(7):542-554. doi: 10.1016/j.molmed.2022.04.007. Epub 2022 Apr 21. Trends Mol Med. 2022. PMID: 35537987 Free PMC article. Review.

29

New Metabolites from the Marine Sponge Scopalina hapalia Collected in Mayotte Lagoon.

Saïd Hassane C, Herbette G, Garayev E, Mabrouki F, Clerc P, de Voogd NJ, Greff S, Trougakos IP, Ouazzani J, Fouillaud M, Dufossé L, Baghdikian B, Ollivier E, Gauvin-Bialecki A. Saïd Hassane C, et al. Among authors: trougakos ip. Mar Drugs. 2022 Mar 2;20(3):186. doi: 10.3390/md20030186. Mar Drugs. 2022. PMID: 35323485 Free PMC article.

30

Oxidative stress and endogenous DNA damage in blood mononuclear cells may predict anti-SARS-CoV-2 antibody titers after vaccination in older adults.

Ntouros PA, Kravvariti E, Vlachogiannis NI, Pappa M, Trougakos IP, Terpos E, Tektonidou MG, Souliotis VL, Sfikakis PP. Ntouros PA, et al. Among authors: trougakos ip. Biochim Biophys Acta Mol Basis Dis. 2022 Jun 1;1868(6):166393. doi: 10.1016/j.bbadis.2022.166393. Epub 2022 Mar 18. Biochim Biophys Acta Mol Basis Dis. 2022. PMID: 35314351 Free PMC article.

31

Clusterin in Alzheimer's disease: An amyloidogenic inhibitor of amyloid formation?

Spatharas PM, Nasi GI, Tsiolaki PL, Theodoropoulou MK, Papandreou NC, Hoenger A, Trougakos IP, Iconomidou VA. Spatharas PM, et al. Among authors: trougakos ip. Biochim Biophys Acta Mol Basis Dis. 2022 Jul 1;1868(7):166384. doi: 10.1016/j.bbadis.2022.166384. Epub 2022 Mar 13. Biochim Biophys Acta Mol Basis Dis. 2022. PMID: 35292360 Free article.

32

Immune response and adverse events after vaccination against SARS-CoV-2 in adult patients with transfusion-dependent thalassaemia.

Delaporta P, Terpos E, Solomou EE, Gumeni S, Nitsa E, Apostolakou F, Kyriakopoulou D, Ntanasis-Stathopoulos I, Papassotiriou I, Trougakos IP, Dimopoulos MA, Kattamis A. Delaporta P, et al. Among authors: trougakos ip. Br J Haematol. 2022 Jun;197(5):576-579. doi: 10.1111/bjh.18146. Epub 2022 Mar 14. Br J Haematol. 2022. PMID: 35286720 Free PMC article.

33

Patients With Autoimmune Thyroiditis Present Similar Immunological Response to COVID-19 BNT162b2 mRNA Vaccine With Healthy Subjects, While Vaccination May Affect Thyroid Function: A Clinical Study.

Paschou SA, Karalis V, Psaltopoulou T, Vasileiou V, Charitaki I, Bagratuni T, Ktena V, Papandroulaki F, Gumeni S, Kassi GN, Trougakos IP, Terpos E, Dimopoulos MA. Paschou SA, et al. Among authors: trougakos ip. Front Endocrinol (Lausanne). 2022 Feb 22;13:840668. doi: 10.3389/fendo.2022.840668. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35273575 Free PMC article.

34

Comparison of Neutralizing Antibody Responses at 6 Months Post Vaccination with BNT162b2 and AZD1222.

Terpos E, Karalis V, Ntanasis-Stathopoulos I, Evangelakou Z, Gavriatopoulou M, Manola MS, Malandrakis P, Gianniou DD, Kastritis E, Trougakos IP, Dimopoulos MA. Terpos E, et al. Among authors: trougakos ip. Biomedicines. 2022 Feb 1;10(2):338. doi: 10.3390/biomedicines10020338. Biomedicines. 2022. PMID: 35203547 Free PMC article.

35

Predictive Factors for Neutralizing Antibody Levels Nine Months after Full Vaccination with BNT162b2: Results of a Machine Learning Analysis.

Papadopoulos D, Ntanasis-Stathopoulos I, Gavriatopoulou M, Evangelakou Z, Malandrakis P, Manola MS, Gianniou DD, Kastritis E, Trougakos IP, Dimopoulos MA, Karalis V, Terpos E. Papadopoulos D, et al. Among authors: trougakos ip. Biomedicines. 2022 Jan 18;10(2):204. doi: 10.3390/biomedicines10020204. Biomedicines. 2022. PMID: 35203412 Free PMC article.

36

Comoclathrin, a novel potent skin-whitening agent produced by endophytic Comoclathris strains associated with Andalusia desert plants.

Georgousaki K, González-Menéndez V, Tormo JR, Tsafantakis N, Mackenzie TA, Martín J, Gumeni S, Trougakos IP, Reyes F, Fokialakis N, Genilloud O. Georgousaki K, et al. Among authors: trougakos ip. Sci Rep. 2022 Jan 31;12(1):1649. doi: 10.1038/s41598-022-05448-9. Sci Rep. 2022. PMID: 35102193 Free PMC article.

37

Third dose of the BNT162b2 vaccine results in very high levels of neutralizing antibodies against SARS-CoV-2: Results of a prospective study in 150 health professionals in Greece.

Terpos E, Karalis V, Sklirou AD, Apostolakou F, Ntanasis-Stathopoulos I, Bagratuni T, Iconomidou VA, Malandrakis P, Korompoki E, Papassotiriou I, Trougakos IP, Dimopoulos MA. Terpos E, et al. Among authors: trougakos ip. Am J Hematol. 2022 Apr;97(4):E147-E150. doi: 10.1002/ajh.26468. Epub 2022 Jan 25. Am J Hematol. 2022. PMID: 35025124 Free PMC article. No abstract available.

38

Arabidopsis thaliana Plant Natriuretic Peptide Active Domain Forms Amyloid-like Fibrils in a pH-Dependent Manner.

Nasi GI, Aktypi FD, Spatharas PM, Louros NN, Tsiolaki PL, Magafa V, Trougakos IP, Iconomidou VA. Nasi GI, et al. Among authors: trougakos ip. Plants (Basel). 2021 Dec 21;11(1):9. doi: 10.3390/plants11010009. Plants (Basel). 2021. PMID: 35009013 Free PMC article.

39

Booster BNT162b2 optimizes SARS-CoV-2 humoral response in patients with myeloma: the negative effect of anti-BCMA therapy.

Terpos E, Gavriatopoulou M, Ntanasis-Stathopoulos I, Briasoulis A, Gumeni S, Malandrakis P, Papanagnou ED, Migkou M, Kanellias N, Kastritis E, Trougakos IP, Dimopoulos MA. Terpos E, et al. Among authors: trougakos ip. Blood. 2022 Mar 3;139(9):1409-1412. doi: 10.1182/blood.2021014989. Blood. 2022. PMID: 34986251 Free PMC article. Clinical Trial. No abstract available.

40

Differential Dose- and Tissue-Dependent Effects of foxo on Aging, Metabolic and Proteostatic Pathways.

Manola MS, Gumeni S, Trougakos IP. Manola MS, et al. Among authors: trougakos ip. Cells. 2021 Dec 18;10(12):3577. doi: 10.3390/cells10123577. Cells. 2021. PMID: 34944088 Free PMC article.

41

Sustained but Declining Humoral Immunity Against SARS-CoV-2 at 9 Months Postvaccination With BNT162b2: A Prospective Evaluation in 309 Healthy Individuals.

Terpos E, Karalis V, Ntanasis-Stathopoulos I, Apostolakou F, Gumeni S, Gavriatopoulou M, Papadopoulos D, Malandrakis P, Papanagnou ED, Korompoki E, Kastritis E, Papassotiriou I, Trougakos IP, Dimopoulos MA. Terpos E, et al. Among authors: trougakos ip. Hemasphere. 2021 Dec 17;6(1):e677. doi: 10.1097/HS9.0000000000000677. eCollection 2022 Jan. Hemasphere. 2021. PMID: 34938959 Free PMC article.

42

Determination of MYD88L265P mutation fraction in IgM monoclonal gammopathies.

Bagratuni T, Markou A, Patseas D, Mavrianou-Koutsoukou N, Aktypi F, Liacos CI, Sklirou AD, Theodorakakou F, Ntanasis-Stathopoulos I, Gavriatopoulou M, Trougakos IP, Lianidou E, Terpos E, Kastritis E, Dimopoulos MA. Bagratuni T, et al. Among authors: trougakos ip. Blood Adv. 2022 Jan 11;6(1):189-199. doi: 10.1182/bloodadvances.2021005354. Blood Adv. 2022. PMID: 34788399 Free PMC article.

43

Kinetics of anti-SARS-CoV-2 neutralizing antibodies development after BNT162b2 vaccination in patients with amyloidosis and the impact of therapy.

Kastritis E, Terpos E, Evangelakou Z, Theodorakakou F, Fotiou D, Manola MS, Gianniou DD, Bagratuni T, Kanellias N, Migkou M, Gavriatopoulou M, Trougakos IP, Dimopoulos MA. Kastritis E, et al. Among authors: trougakos ip. Am J Hematol. 2022 Jan 1;97(1):E27-E31. doi: 10.1002/ajh.26406. Epub 2021 Nov 23. Am J Hematol. 2022. PMID: 34778995 Free PMC article. Clinical Trial. No abstract available.

44

Immunological Response to COVID-19 Vaccination in Ovarian Cancer Patients Receiving PARP Inhibitors.

Liontos M, Terpos E, Markellos C, Zagouri F, Briasoulis A, Katsiana I, Skafida E, Fiste O, Kunadis E, Andrikopoulou A, Kaparelou M, Koutsoukos K, Gavriatopoulou M, Kastritis E, Trougakos IP, Dimopoulos MA. Liontos M, et al. Among authors: trougakos ip. Vaccines (Basel). 2021 Oct 8;9(10):1148. doi: 10.3390/vaccines9101148. Vaccines (Basel). 2021. PMID: 34696256 Free PMC article.

45

Robust Neutralizing Antibody Responses 6 Months Post Vaccination with BNT162b2: A Prospective Study in 308 Healthy Individuals.

Terpos E, Karalis V, Ntanasis-Stathopoulos I, Gavriatopoulou M, Gumeni S, Malandrakis P, Papanagnou ED, Kastritis E, Trougakos IP, Dimopoulos MA. Terpos E, et al. Among authors: trougakos ip. Life (Basel). 2021 Oct 12;11(10):1077. doi: 10.3390/life11101077. Life (Basel). 2021. PMID: 34685448 Free PMC article.

46

Elucidating Carfilzomib's Induced Cardiotoxicity in an In Vivo Model of Aging: Prophylactic Potential of Metformin.

Efentakis P, Psarakou G, Varela A, Papanagnou ED, Chatzistefanou M, Nikolaou PE, Davos CH, Gavriatopoulou M, Trougakos IP, Dimopoulos MA, Andreadou I, Terpos E. Efentakis P, et al. Among authors: trougakos ip. Int J Mol Sci. 2021 Oct 11;22(20):10956. doi: 10.3390/ijms222010956. Int J Mol Sci. 2021. PMID: 34681615 Free PMC article.

47

Blood Transcriptomes of Anti-SARS-CoV-2 Antibody-Positive Healthy Individuals Who Experienced Asymptomatic Versus Clinical Infection.

Sfikakis PP, Verrou KM, Ampatziadis-Michailidis G, Tsitsilonis O, Paraskevis D, Kastritis E, Lianidou E, Moutsatsou P, Terpos E, Trougakos I, Chini V, Manoloukos M, Moulos P, Pavlopoulos GA, Kollias G, Hatzis P, Dimopoulos MA. Sfikakis PP, et al. Among authors: trougakos i. Front Immunol. 2021 Oct 5;12:746203. doi: 10.3389/fimmu.2021.746203. eCollection 2021. Front Immunol. 2021. PMID: 34675930 Free PMC article.

48

Distinct neutralization profile of spike variants by antibodies induced upon SARS-CoV-2 infection or vaccination.

Rosati M, Terpos E, Agarwal M, Karalis V, Bear J, Burns R, Hu X, Papademetriou D, Ntanasis-Stathopoulos I, Trougakos IP, Dimopoulos MA, Pavlakis GN, Felber BK. Rosati M, et al. Among authors: trougakos ip. Am J Hematol. 2022 Jan 1;97(1):E3-E7. doi: 10.1002/ajh.26380. Epub 2021 Nov 5. Am J Hematol. 2022. PMID: 34674297 Free PMC article. Clinical Trial. No abstract available.

49

Resistance to Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia-From Molecular Mechanisms to Clinical Relevance.

Alves R, Gonçalves AC, Rutella S, Almeida AM, De Las Rivas J, Trougakos IP, Sarmento Ribeiro AB. Alves R, et al. Among authors: trougakos ip. Cancers (Basel). 2021 Sep 26;13(19):4820. doi: 10.3390/cancers13194820. Cancers (Basel). 2021. PMID: 34638304 Free PMC article. Review.

50

Treatment with abiraterone or enzalutamide does not impair immunological response to COVID-19 vaccination in prostate cancer patients.

Liontos M, Terpos E, Kunadis E, Zagouri F, Briasoulis A, Skafida E, Fiste O, Markellos C, Andrikopoulou A, Gumeni S, Kaparelou M, Koutsoukos K, Gavriatopoulou M, Kastritis E, Trougakos IP, Dimopoulos MA. Liontos M, et al. Among authors: trougakos ip. Prostate Cancer Prostatic Dis. 2022 Mar;25(1):117-118. doi: 10.1038/s41391-021-00455-9. Epub 2021 Oct 9. Prostate Cancer Prostatic Dis. 2022. PMID: 34628475 Free PMC article.

51

An enriched polyphenolic extract obtained from the by-product of Rosa damascena hydrodistillation activates antioxidant and proteostatic modules.

Dina E, Sklirou AD, Chatzigeorgiou S, Manola MS, Cheilari A, Louka XP, Argyropoulou A, Xynos N, Skaltsounis AL, Aligiannis N, Trougakos IP. Dina E, et al. Among authors: trougakos ip. Phytomedicine. 2021 Dec;93:153757. doi: 10.1016/j.phymed.2021.153757. Epub 2021 Sep 15. Phytomedicine. 2021. PMID: 34619431 Free article.

52

Micro-CT for Biological and Biomedical Studies: A Comparison of Imaging Techniques.

Keklikoglou K, Arvanitidis C, Chatzigeorgiou G, Chatzinikolaou E, Karagiannidis E, Koletsa T, Magoulas A, Makris K, Mavrothalassitis G, Papanagnou ED, Papazoglou AS, Pavloudi C, Trougakos IP, Vasileiadou K, Vogiatzi A. Keklikoglou K, et al. Among authors: trougakos ip. J Imaging. 2021 Sep 1;7(9):172. doi: 10.3390/jimaging7090172. J Imaging. 2021. PMID: 34564098 Free PMC article. Review.

53

Poor neutralizing antibody responses in 106 patients with WM after vaccination against SARS-CoV-2: a prospective study.

Gavriatopoulou M, Terpos E, Ntanasis-Stathopoulos I, Briasoulis A, Gumeni S, Malandrakis P, Fotiou D, Migkou M, Theodorakakou F, Eleutherakis-Papaiakovou E, Kanellias N, Kastritis E, Trougakos IP, Dimopoulos MA. Gavriatopoulou M, et al. Among authors: trougakos ip. Blood Adv. 2021 Nov 9;5(21):4398-4405. doi: 10.1182/bloodadvances.2021005444. Blood Adv. 2021. PMID: 34529762 Free PMC article. Clinical Trial.

54

Myeloma patients with COVID-19 have superior antibody responses compared to patients fully vaccinated with the BNT162b2 vaccine.

Gavriatopoulou M, Terpos E, Malandrakis P, Ntanasis-Stathopoulos I, Briasoulis A, Gumeni S, Fotiou D, Papanagnou ED, Migkou M, Theodorakakou F, Eleutherakis-Papaiakovou E, Kanellias N, Trougakos IP, Kastritis E, Dimopoulos MA. Gavriatopoulou M, et al. Among authors: trougakos ip. Br J Haematol. 2022 Jan;196(2):356-359. doi: 10.1111/bjh.17841. Epub 2021 Sep 16. Br J Haematol. 2022. PMID: 34528249 Free PMC article.

55

Poor Neutralizing Antibody Responses in 132 Patients with CLL, NHL and HL after Vaccination against SARS-CoV-2: A Prospective Study.

Terpos E, Gavriatopoulou M, Fotiou D, Giatra C, Asimakopoulos I, Dimou M, Sklirou AD, Ntanasis-Stathopoulos I, Darmani I, Briasoulis A, Kastritis E, Angelopoulou M, Baltadakis I, Panayiotidis P, Trougakos IP, Vassilakopoulos TP, Pagoni M, Dimopoulos MA. Terpos E, et al. Among authors: trougakos ip. Cancers (Basel). 2021 Sep 6;13(17):4480. doi: 10.3390/cancers13174480. Cancers (Basel). 2021. PMID: 34503290 Free PMC article.

56

Apoptosis Deregulation and the Development of Cancer Multi-Drug Resistance.

Neophytou CM, Trougakos IP, Erin N, Papageorgis P. Neophytou CM, et al. Among authors: trougakos ip. Cancers (Basel). 2021 Aug 28;13(17):4363. doi: 10.3390/cancers13174363. Cancers (Basel). 2021. PMID: 34503172 Free PMC article. Review.

57

SARS-CoV-2 neutralizing antibodies after first vaccination dose in breast cancer patients receiving CDK4/6 inhibitors.

Zagouri F, Terpos E, Fiste O, Liontos M, Briasoulis A, Katsiana I, Skafida E, Markellos C, Kunadis E, Andrikopoulou A, Kaparelou M, Koutsoukos K, Gavriatopoulou M, Kastritis E, Trougakos IP, Dimopoulos MA. Zagouri F, et al. Among authors: trougakos ip. Breast. 2021 Dec;60:58-61. doi: 10.1016/j.breast.2021.08.017. Epub 2021 Aug 28. Breast. 2021. PMID: 34481366 Free PMC article.

58

Novel Nested-Seq Approach for SARS-CoV-2 Real-Time Epidemiology and In-Depth Mutational Profiling in Wastewater.

Avgeris M, Adamopoulos PG, Galani A, Xagorari M, Gourgiotis D, Trougakos IP, Voulgaris N, Dimopoulos MA, Thomaidis NS, Scorilas A. Avgeris M, et al. Among authors: trougakos ip. Int J Mol Sci. 2021 Aug 7;22(16):8498. doi: 10.3390/ijms22168498. Int J Mol Sci. 2021. PMID: 34445204 Free PMC article.

59

Kinetics of Anti-SARS-CoV-2 Antibody Responses 3 Months Post Complete Vaccination with BNT162b2; A Prospective Study in 283 Health Workers.

Terpos E, Trougakos IP, Karalis V, Ntanasis-Stathopoulos I, Gumeni S, Apostolakou F, Sklirou AD, Gavriatopoulou M, Skourti S, Kastritis E, Korompoki E, Papassotiriou I, Dimopoulos MA. Terpos E, et al. Among authors: trougakos ip. Cells. 2021 Jul 30;10(8):1942. doi: 10.3390/cells10081942. Cells. 2021. PMID: 34440710 Free PMC article.

60

Phytochemical Study and In Vitro Screening Focusing on the Anti-Aging Features of Various Plants of the Greek Flora.

Sklirou AD, Angelopoulou MT, Argyropoulou A, Chaita E, Boka VI, Cheimonidi C, Niforou K, Mavrogonatou E, Pratsinis H, Kalpoutzakis E, Aligiannis N, Kletsas D, Trougakos IP, Skaltsounis AL. Sklirou AD, et al. Among authors: trougakos ip. Antioxidants (Basel). 2021 Jul 28;10(8):1206. doi: 10.3390/antiox10081206. Antioxidants (Basel). 2021. PMID: 34439454 Free PMC article.

61

Comparative kinetics of SARS-CoV-2 anti-spike protein RBD IgGs and neutralizing antibodies in convalescent and naïve recipients of the BNT162b2 mRNA vaccine versus COVID-19 patients.

Trougakos IP, Terpos E, Zirou C, Sklirou AD, Apostolakou F, Gumeni S, Charitaki I, Papanagnou ED, Bagratuni T, Liacos CI, Scorilas A, Korompoki E, Papassotiriou I, Kastritis E, Dimopoulos MA. Trougakos IP, et al. BMC Med. 2021 Aug 23;19(1):208. doi: 10.1186/s12916-021-02090-6. BMC Med. 2021. PMID: 34420521 Free PMC article.

62

High Prevalence of Anti-PF4 Antibodies Following ChAdOx1 nCov-19 (AZD1222) Vaccination Even in the Absence of Thrombotic Events.

Terpos E, Politou M, Ntanasis-Stathopoulos I, Karalis V, Merkouri E, Fotiou D, Gavriatopoulou M, Malandrakis P, Kastritis E, Trougakos IP, Dimopoulos MA. Terpos E, et al. Among authors: trougakos ip. Vaccines (Basel). 2021 Jul 1;9(7):712. doi: 10.3390/vaccines9070712. Vaccines (Basel). 2021. PMID: 34358129 Free PMC article.

63

Systemic IL-15, IFN-γ, and IP-10/CXCL10 signature associated with effective immune response to SARS-CoV-2 in BNT162b2 mRNA vaccine recipients.

Bergamaschi C, Terpos E, Rosati M, Angel M, Bear J, Stellas D, Karaliota S, Apostolakou F, Bagratuni T, Patseas D, Gumeni S, Trougakos IP, Dimopoulos MA, Felber BK, Pavlakis GN. Bergamaschi C, et al. Among authors: trougakos ip. Cell Rep. 2021 Aug 10;36(6):109504. doi: 10.1016/j.celrep.2021.109504. Epub 2021 Jul 23. Cell Rep. 2021. PMID: 34352226 Free PMC article.

64

The neutralizing antibody response post COVID-19 vaccination in patients with myeloma is highly dependent on the type of anti-myeloma treatment.

Terpos E, Gavriatopoulou M, Ntanasis-Stathopoulos I, Briasoulis A, Gumeni S, Malandrakis P, Fotiou D, Papanagnou ED, Migkou M, Theodorakakou F, Roussou M, Eleutherakis-Papaiakovou E, Kanellias N, Trougakos IP, Kastritis E, Dimopoulos MA. Terpos E, et al. Among authors: trougakos ip. Blood Cancer J. 2021 Aug 2;11(8):138. doi: 10.1038/s41408-021-00530-3. Blood Cancer J. 2021. PMID: 34341335 Free PMC article.

65

Low neutralizing antibody responses in WM, CLL and NHL patients after the first dose of the BNT162b2 and AZD1222 vaccine.

Gavriatopoulou M, Terpos E, Kastritis E, Briasoulis A, Gumeni S, Ntanasis-Stathopoulos I, Sklirou AD, Malandrakis P, Eleutherakis-Papaiakovou E, Migkou M, Trougakos IP, Dimopoulos MA. Gavriatopoulou M, et al. Among authors: trougakos ip. Clin Exp Med. 2022 May;22(2):319-323. doi: 10.1007/s10238-021-00746-4. Epub 2021 Jul 20. Clin Exp Med. 2022. PMID: 34283338 Free PMC article.

66

Antibody Response After Initial Vaccination for SARS-CoV-2 in Patients With Amyloidosis.

Kastritis E, Terpos E, Sklirou A, Theodorakakou F, Fotiou D, Papanagnou ED, Bagratuni T, Kanellias N, Gavriatopoulou M, Trougakos IP, Dimopoulos MA. Kastritis E, et al. Among authors: trougakos ip. Hemasphere. 2021 Jul 15;5(8):e614. doi: 10.1097/HS9.0000000000000614. eCollection 2021 Aug. Hemasphere. 2021. PMID: 34278231 Free PMC article. No abstract available.

67

Nrf2 activation induces mitophagy and reverses Parkin/Pink1 knock down-mediated neuronal and muscle degeneration phenotypes.

Gumeni S, Papanagnou ED, Manola MS, Trougakos IP. Gumeni S, et al. Among authors: trougakos ip. Cell Death Dis. 2021 Jul 3;12(7):671. doi: 10.1038/s41419-021-03952-w. Cell Death Dis. 2021. PMID: 34218254 Free PMC article.

68

Amyloid toxicity in a Drosophila Alzheimer's model is ameliorated by autophagy activation.

Tsakiri EN, Gumeni S, Manola MS, Trougakos IP. Tsakiri EN, et al. Among authors: trougakos ip. Neurobiol Aging. 2021 Sep;105:137-147. doi: 10.1016/j.neurobiolaging.2021.04.017. Epub 2021 Apr 28. Neurobiol Aging. 2021. PMID: 34062489

69

Low titers of SARS-CoV-2 neutralizing antibodies after first vaccination dose in cancer patients receiving checkpoint inhibitors.

Terpos E, Zagouri F, Liontos M, Sklirou AD, Koutsoukos K, Markellos C, Briasoulis A, Papanagnou ED, Trougakos IP, Dimopoulos MA. Terpos E, et al. Among authors: trougakos ip. J Hematol Oncol. 2021 May 31;14(1):86. doi: 10.1186/s13045-021-01099-x. J Hematol Oncol. 2021. PMID: 34059088 Free PMC article.

70

Comparison of neutralizing antibody responses against SARS-CoV-2 in healthy volunteers who received the BNT162b2 mRNA or the AZD1222 vaccine: Should the second AZD1222 vaccine dose be given earlier?

Terpos E, Trougakos IP, Karalis V, Ntanasis-Stathopoulos I, Sklirou AD, Bagratuni T, Papanagnou ED, Patseas D, Gumeni S, Malandrakis P, Korompoki E, Dimopoulos MA. Terpos E, et al. Among authors: trougakos ip. Am J Hematol. 2021 Sep 1;96(9):E321-E324. doi: 10.1002/ajh.26248. Epub 2021 Jun 2. Am J Hematol. 2021. PMID: 34028867 Free PMC article. No abstract available.

71

Correction to: A prototypical non-malignant epithelial model to study genome dynamics and concurrently monitor micro-RNAs and proteins in situ during oncogene-induced senescence.

Komseli ES, Pateras IS, Krejsgaard T, Stawiski K, Rizou SV, Polyzos A, Roumelioti FM, Chiourea M, Mourkioti I, Paparouna E, Zampetidis CP, Gumeni S, Trougakos IP, Pefani DE, O'Neill E, Gagos S, Eliopoulos AG, Fendler W, Chowdhury D, Bartek J, Gorgoulis VG. Komseli ES, et al. Among authors: trougakos ip. BMC Genomics. 2021 May 5;22(1):327. doi: 10.1186/s12864-021-07608-z. BMC Genomics. 2021. PMID: 33952190 Free PMC article. No abstract available.

72

Low neutralizing antibody responses against SARS-CoV-2 in older patients with myeloma after the first BNT162b2 vaccine dose.

Terpos E, Trougakos IP, Gavriatopoulou M, Papassotiriou I, Sklirou AD, Ntanasis-Stathopoulos I, Papanagnou ED, Fotiou D, Kastritis E, Dimopoulos MA. Terpos E, et al. Among authors: trougakos ip. Blood. 2021 Jul 1;137(26):3674-3676. doi: 10.1182/blood.2021011904. Blood. 2021. PMID: 33861315 Free PMC article. No abstract available.

73

Age-dependent and gender-dependent antibody responses against SARS-CoV-2 in health workers and octogenarians after vaccination with the BNT162b2 mRNA vaccine.

Terpos E, Trougakos IP, Apostolakou F, Charitaki I, Sklirou AD, Mavrianou N, Papanagnou ED, Liacos CI, Gumeni S, Rentziou G, Korompoki E, Papassotiriou I, Dimopoulos MA. Terpos E, et al. Among authors: trougakos ip. Am J Hematol. 2021 Jul 1;96(7):E257-E259. doi: 10.1002/ajh.26185. Epub 2021 Apr 24. Am J Hematol. 2021. PMID: 33837984 Free PMC article. No abstract available.

74

SARS-CoV-2 Infection Is Asymptomatic in Nearly Half of Adults with Robust Anti-Spike Protein Receptor-Binding Domain Antibody Response.

Tsitsilonis OE, Paraskevis D, Lianidou E, Terpos E, Akalestos A, Pierros V, Kostaki EG, Kastritis E, Moutsatsou P, Politou M, Scorilas A, Sphicopoulos T, Thomaidis N, Trougakos IP, Tsakris A, Voulgaris N, Daskalaki CC, Evangelakou Z, Fouki C, Gianniou DD, Gumeni S, Kostopoulos IV, Manola MS, Orologas-Stavrou N, Panteli C, Papanagnou ED, Rousakis P, Sklirou AD, Smilkou S, Stergiopoulou D, Tsiodras S, Dimopoulos MA, Sfikakis PP. Tsitsilonis OE, et al. Among authors: trougakos ip. Vaccines (Basel). 2021 Mar 2;9(3):207. doi: 10.3390/vaccines9030207. Vaccines (Basel). 2021. PMID: 33801380 Free PMC article.

75

Recovery of Innate Immune Cells and Persisting Alterations in Adaptive Immunity in the Peripheral Blood of Convalescent Plasma Donors at Eight Months Post SARS-CoV-2 Infection.

Kostopoulos IV, Orologas-Stavrou N, Rousakis P, Panteli C, Ntanasis-Stathopoulos I, Charitaki I, Korompoki E, Gavriatopoulou M, Kastritis E, Trougakos IP, Dimopoulos MA, Tsitsilonis OE, Terpos E. Kostopoulos IV, et al. Among authors: trougakos ip. Microorganisms. 2021 Mar 6;9(3):546. doi: 10.3390/microorganisms9030546. Microorganisms. 2021. PMID: 33800807 Free PMC article.

76

Accurate SARS-CoV-2 seroprevalence surveys require robust multi-antigen assays.

Fotis C, Meimetis N, Tsolakos N, Politou M, Akinosoglou K, Pliaka V, Minia A, Terpos E, Trougakos IP, Mentis A, Marangos M, Panayiotakopoulos G, Dimopoulos MA, Gogos C, Spyridonidis A, Alexopoulos LG. Fotis C, et al. Among authors: trougakos ip. Sci Rep. 2021 Mar 23;11(1):6614. doi: 10.1038/s41598-021-86035-2. Sci Rep. 2021. PMID: 33758278 Free PMC article.

77

Clusterin overexpression in mice exacerbates diabetic phenotypes but suppresses tumor progression in a mouse melanoma model.

Cheimonidi C, Grivas IN, Sesti F, Kavrochorianou N, Gianniou DD, Taoufik E, Badounas F, Papassideri I, Rizzi F, Tsitsilonis OE, Haralambous S, Trougakos IP. Cheimonidi C, et al. Among authors: trougakos ip. Aging (Albany NY). 2021 Mar 10;13(5):6485-6505. doi: 10.18632/aging.202788. Epub 2021 Mar 10. Aging (Albany NY). 2021. PMID: 33744871 Free PMC article.

78

Elastase inhibitory activity of secondary metabolites from the fungus Virgaria nigra CF-231658.

Samy MN, Le Goff G, Lopes P, Georgousaki K, Gumeni S, Almeida C, Gonzalez-Menendez V, Genilloud O, Trougakos IP, Fokialakis N, Ouazzani J. Samy MN, et al. Among authors: trougakos ip. Nat Prod Res. 2022 Mar;36(6):1668-1671. doi: 10.1080/14786419.2021.1899175. Epub 2021 Mar 11. Nat Prod Res. 2022. PMID: 33706628

79

Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)¹.

Klionsky DJ, Abdel-Aziz AK, Abdelfatah S, Abdellatif M, Abdoli A, Abel S, Abeliovich H, Abildgaard MH, Abudu YP, Acevedo-Arozena A, Adamopoulos IE, Adeli K, Adolph TE, Adornetto A, Aflaki E, Agam G, Agarwal A, Aggarwal BB, Agnello M, Agostinis P, Agrewala JN, Agrotis A, Aguilar PV, Ahmad ST, Ahmed ZM, Ahumada-Castro U, Aits S, Aizawa S, Akkoc Y, Akoumianaki T, Akpinar HA, Al-Abd AM, Al-Akra L, Al-Gharaibeh A, Alaoui-Jamali MA, Alberti S, Alcocer-Gómez E, Alessandri C, Ali M, Alim Al-Bari MA, Aliwaini S, Alizadeh J, Almacellas E, Almasan A, Alonso A, Alonso GD, Altan-Bonnet N, Altieri DC, Álvarez ÉMC, Alves S, Alves da Costa C, Alzaharna MM, Amadio M, Amantini C, Amaral C, Ambrosio S, Amer AO, Ammanathan V, An Z, Andersen SU, Andrabi SA, Andrade-Silva M, Andres AM, Angelini S, Ann D, Anozie UC, Ansari MY, Antas P, Antebi A, Antón Z, Anwar T, Apetoh L, Apostolova N, Araki T, Araki Y, Arasaki K, Araújo WL, Araya J, Arden C, Arévalo MA, Arguelles S, Arias E, Arikkath J, Arimoto H, Ariosa AR, Armstrong-James D, Arnauné-Pelloquin L, Aroca A, Arroyo DS, Arsov I, Artero R, Asaro DML, Aschner M, Ashrafizadeh M, Ashur-Fabian O, Atanasov AG, Au AK, Auberger P, Auner HW, Aurelian L, Autelli R… See abstract for full author list ➔ Klionsky DJ, et al. Among authors: trougakos ip. Autophagy. 2021 Jan;17(1):1-382. doi: 10.1080/15548627.2020.1797280. Epub 2021 Feb 8. Autophagy. 2021. PMID: 33634751 Free PMC article.

80

Carfilzomib-induced endothelial dysfunction, recovery of proteasome activity, and prediction of cardiovascular complications: a prospective study.

Kastritis E, Laina A, Georgiopoulos G, Gavriatopoulou M, Papanagnou ED, Eleutherakis-Papaiakovou E, Fotiou D, Kanellias N, Dialoupi I, Makris N, Manios E, Migkou M, Roussou M, Kotsopoulou M, Stellos K, Terpos E, Trougakos IP, Stamatelopoulos K, Dimopoulos MA. Kastritis E, et al. Among authors: trougakos ip. Leukemia. 2021 May;35(5):1418-1427. doi: 10.1038/s41375-021-01141-4. Epub 2021 Feb 15. Leukemia. 2021. PMID: 33589757 Clinical Trial.

81

Insights to SARS-CoV-2 life cycle, pathophysiology, and rationalized treatments that target COVID-19 clinical complications.

Trougakos IP, Stamatelopoulos K, Terpos E, Tsitsilonis OE, Aivalioti E, Paraskevis D, Kastritis E, Pavlakis GN, Dimopoulos MA. Trougakos IP, et al. J Biomed Sci. 2021 Jan 12;28(1):9. doi: 10.1186/s12929-020-00703-5. J Biomed Sci. 2021. PMID: 33435929 Free PMC article. Review.

82

Bromamine T (BAT) Exerts Stronger Anti-Cancer Properties than Taurine (Tau).

Baliou S, Goulielmaki M, Ioannou P, Cheimonidi C, Trougakos IP, Nagl M, Kyriakopoulos AM, Zoumpourlis V. Baliou S, et al. Among authors: trougakos ip. Cancers (Basel). 2021 Jan 7;13(2):182. doi: 10.3390/cancers13020182. Cancers (Basel). 2021. PMID: 33430276 Free PMC article.

83

Characterization of a PERK Kinase Inhibitor with Anti-Myeloma Activity.

Bagratuni T, Patseas D, Mavrianou-Koutsoukou N, Liacos CI, Sklirou AD, Rousakis P, Gavriatopoulou M, Terpos E, Tsitsilonis OE, Trougakos IP, Kastritis E, Dimopoulos MA. Bagratuni T, et al. Among authors: trougakos ip. Cancers (Basel). 2020 Oct 5;12(10):2864. doi: 10.3390/cancers12102864. Cancers (Basel). 2020. PMID: 33028016 Free PMC article.

84

Seroprevalence of Antibodies against SARS-CoV-2 among the Personnel and Students of the National and Kapodistrian University of Athens, Greece: A Preliminary Report.

Tsitsilonis OE, Paraskevis D, Lianidou E, Pierros V, Akalestos A, Kastritis E, Moutsatsou P, Scorilas A, Sphicopoulos T, Terpos E, Thomaidis N, Tsakris A, Voulgaris N, Daskalaki CC, Evangelakou Z, Fouki C, Gianniou DD, Gumeni S, Kostaki EG, Kostopoulos IV, Manola MS, Orologas-Stavrou N, Panteli C, Papanagnou ED, Rousakis P, Sklirou AD, Smilkou S, Stergiopoulou D, Trougakos IP, Tsiodras S, Sfikakis PP, Dimopoulos MA. Tsitsilonis OE, et al. Among authors: trougakos ip. Life (Basel). 2020 Sep 21;10(9):214. doi: 10.3390/life10090214. Life (Basel). 2020. PMID: 32967110 Free PMC article.

85

The Transcriptomic Response of the Murine Thyroid Gland to Iodide Overload and the Role of the Nrf2 Antioxidant System.

Chartoumpekis DV, Ziros PG, Georgakopoulos-Soares I, Smith AAT, Marques AC, Ibberson M, A Kopp P, Habeos I, Trougakos IP, Khoo NKH, Sykiotis GP. Chartoumpekis DV, et al. Among authors: trougakos ip. Antioxidants (Basel). 2020 Sep 18;9(9):884. doi: 10.3390/antiox9090884. Antioxidants (Basel). 2020. PMID: 32961913 Free PMC article.

86

Expression profiling meta-analysis of ACE2 and TMPRSS2, the putative anti-inflammatory receptor and priming protease of SARS-CoV-2 in human cells, and identification of putative modulators.

Gkogkou E, Barnasas G, Vougas K, Trougakos IP. Gkogkou E, et al. Among authors: trougakos ip. Redox Biol. 2020 Sep;36:101615. doi: 10.1016/j.redox.2020.101615. Epub 2020 Jun 24. Redox Biol. 2020. PMID: 32863223 Free PMC article.

87

Microorganisms Associated with the Marine Sponge Scopalina hapalia: A Reservoir of Bioactive Molecules to Slow Down the Aging Process.

Said Hassane C, Fouillaud M, Le Goff G, Sklirou AD, Boyer JB, Trougakos IP, Jerabek M, Bignon J, de Voogd NJ, Ouazzani J, Gauvin-Bialecki A, Dufossé L. Said Hassane C, et al. Among authors: trougakos ip. Microorganisms. 2020 Aug 20;8(9):1262. doi: 10.3390/microorganisms8091262. Microorganisms. 2020. PMID: 32825344 Free PMC article.

88

Next generation flow cytometry for MRD detection in patients with AL amyloidosis.

Kastritis E, Kostopoulos IV, Theodorakakou F, Fotiou D, Gavriatopoulou M, Migkou M, Tselegkidi MI, Roussou M, Papathoma A, Eleutherakis-Papaioakovou E, Dialoupi I, Kanellias N, Ntalianis A, Rousakis P, Trougakos IP, Tsitsilonis O, Gakiopoulou C, Terpos E, Dimopoulos MA. Kastritis E, et al. Among authors: trougakos ip. Amyloid. 2021 Mar;28(1):19-23. doi: 10.1080/13506129.2020.1802713. Epub 2020 Aug 12. Amyloid. 2021. PMID: 32783569

89

Osirisynes G-I, New Long-Chain Highly Oxygenated Polyacetylenes from the Mayotte Marine Sponge Haliclona sp.

Campos PE, Herbette G, Chendo C, Clerc P, Tintillier F, de Voogd NJ, Papanagnou ED, Trougakos IP, Jerabek M, Bignon J, Le Goff G, Ouazzani J, Gauvin-Bialecki A. Campos PE, et al. Among authors: trougakos ip. Mar Drugs. 2020 Jul 3;18(7):350. doi: 10.3390/md18070350. Mar Drugs. 2020. PMID: 32635268 Free PMC article.

90

Biological Evaluation and In Silico Study of Benzoic Acid Derivatives from Bjerkandera adusta Targeting Proteostasis Network Modules.

Georgousaki K, Tsafantakis N, Gumeni S, Lambrinidis G, González-Menéndez V, Tormo JR, Genilloud O, Trougakos IP, Fokialakis N. Georgousaki K, et al. Among authors: trougakos ip. Molecules. 2020 Feb 4;25(3):666. doi: 10.3390/molecules25030666. Molecules. 2020. PMID: 32033190 Free PMC article.

91

Inhibition of jasmonate-mediated plant defences by the fungal metabolite higginsianin B.

Dallery JF, Zimmer M, Halder V, Suliman M, Pigné S, Le Goff G, Gianniou DD, Trougakos IP, Ouazzani J, Gasperini D, O'Connell RJ. Dallery JF, et al. Among authors: trougakos ip. J Exp Bot. 2020 May 30;71(10):2910-2921. doi: 10.1093/jxb/eraa061. J Exp Bot. 2020. PMID: 32006004 Free PMC article.

92

Screening for tyrosinase inhibitors from actinomycetes; identification of trichostatin derivatives from Streptomyces sp. CA-129531 and scale up production in bioreactor.

Georgousaki K, Tsafantakis N, Gumeni S, Gonzalez I, Mackenzie TA, Reyes F, Lambert C, Trougakos IP, Genilloud O, Fokialakis N. Georgousaki K, et al. Among authors: trougakos ip. Bioorg Med Chem Lett. 2020 Mar 15;30(6):126952. doi: 10.1016/j.bmcl.2020.126952. Epub 2020 Jan 21. Bioorg Med Chem Lett. 2020. PMID: 32005414

93

Impact of Minimal Residual Disease Detection by Next-Generation Flow Cytometry in Multiple Myeloma Patients with Sustained Complete Remission after Frontline Therapy.

Terpos E, Kostopoulos IV, Kastritis E, Ntanasis-Stathopoulos I, Migkou M, Rousakis P, Argyriou AT, Kanellias N, Fotiou D, Eleutherakis-Papaiakovou E, Gavriatopoulou M, Ziogas DC, Papanota AM, Spyropoulou-Vlachou M, Trougakos IP, Tsitsilonis OE, Paiva B, Dimopoulos MA. Terpos E, et al. Among authors: trougakos ip. Hemasphere. 2019 Oct 1;3(6):e300. doi: 10.1097/HS9.0000000000000300. eCollection 2019 Dec. Hemasphere. 2019. PMID: 31976475 Free PMC article.

94

The emergence of drug resistance to targeted cancer therapies: Clinical evidence.

Sarmento-Ribeiro AB, Scorilas A, Gonçalves AC, Efferth T, Trougakos IP. Sarmento-Ribeiro AB, et al. Among authors: trougakos ip. Drug Resist Updat. 2019 Dec;47:100646. doi: 10.1016/j.drup.2019.100646. Epub 2019 Sep 26. Drug Resist Updat. 2019. PMID: 31733611 Review.

95

Antitumor Reactive T-Cell Responses Are Enhanced In Vivo by DAMP Prothymosin Alpha and Its C-Terminal Decapeptide.

Birmpilis AI, Karachaliou CE, Samara P, Ioannou K, Selemenakis P, Kostopoulos IV, Kavrochorianou N, Kalbacher H, Livaniou E, Haralambous S, Kotsinas A, Farzaneh F, Trougakos IP, Voelter W, Dimopoulos MA, Bamias A, Tsitsilonis O. Birmpilis AI, et al. Among authors: trougakos ip. Cancers (Basel). 2019 Nov 9;11(11):1764. doi: 10.3390/cancers11111764. Cancers (Basel). 2019. PMID: 31717548 Free PMC article.

96

Heat shock protein beta 3 (HSPB3) is an unfavorable molecular biomarker in colorectal adenocarcinoma.

Kalioraki MA, Artemaki PI, Sklirou AD, Kontos CK, Adamopoulos PG, Papadopoulos IN, Trougakos IP, Scorilas A. Kalioraki MA, et al. Among authors: trougakos ip. Mol Carcinog. 2020 Jan;59(1):116-125. doi: 10.1002/mc.23133. Epub 2019 Nov 10. Mol Carcinog. 2020. PMID: 31709619

97

High clusterin (CLU) mRNA expression levels in tumors of colorectal cancer patients predict a poor prognostic outcome.

Artemaki PI, Sklirou AD, Kontos CK, Liosi AA, Gianniou DD, Papadopoulos IN, Trougakos IP, Scorilas A. Artemaki PI, et al. Among authors: trougakos ip. Clin Biochem. 2020 Jan;75:62-69. doi: 10.1016/j.clinbiochem.2019.10.008. Epub 2019 Oct 28. Clin Biochem. 2020. PMID: 31672651

98

Non-lethal proteasome inhibition activates pro-tumorigenic pathways in multiple myeloma cells.

Skorda A, Sklirou AD, Sakellaropoulos T, Gianniou DD, Kastritis E, Terpos E, Tsitsilonis OE, Florea BI, Overkleeft HS, Dimopoulos MA, Alexopoulos LG, Trougakos IP. Skorda A, et al. Among authors: trougakos ip. J Cell Mol Med. 2019 Dec;23(12):8010-8018. doi: 10.1111/jcmm.14653. Epub 2019 Sep 30. J Cell Mol Med. 2019. PMID: 31568628 Free PMC article.

99

What sustains the multidrug resistance phenotype beyond ABC efflux transporters? Looking beyond the tip of the iceberg.

Alexa-Stratulat T, Pešić M, Gašparović AČ, Trougakos IP, Riganti C. Alexa-Stratulat T, et al. Among authors: trougakos ip. Drug Resist Updat. 2019 Sep;46:100643. doi: 10.1016/j.drup.2019.100643. Epub 2019 Aug 23. Drug Resist Updat. 2019. PMID: 31493711 Free article. Review.

100

Nrf2, stress and aging.

Trougakos IP. Trougakos IP. Aging (Albany NY). 2019 Aug 2;11(15):5289-5291. doi: 10.18632/aging.102143. Epub 2019 Aug 2. Aging (Albany NY). 2019. PMID: 31377746 Free PMC article. No abstract available.

101

Alterations in Organismal Physiology, Impaired Stress Resistance, and Accelerated Aging in Drosophila Flies Adapted to Multigenerational Proteome Instability.

Manola MS, Tsakiri EN, Trougakos IP. Manola MS, et al. Among authors: trougakos ip. Oxid Med Cell Longev. 2019 Jun 11;2019:7823285. doi: 10.1155/2019/7823285. eCollection 2019. Oxid Med Cell Longev. 2019. PMID: 31320986 Free PMC article.

102

Osmanicin, a Polyketide Alkaloid Isolated from Streptomyces osmaniensis CA-244599 Inhibits Elastase in Human Fibroblasts.

Samy MN, Le Goff G, Lopes P, Georgousaki K, Gumeni S, Almeida C, González I, Genilloud O, Trougakos I, Fokialakis N, Ouazzani J. Samy MN, et al. Among authors: trougakos i. Molecules. 2019 Jun 15;24(12):2239. doi: 10.3390/molecules24122239. Molecules. 2019. PMID: 31208056 Free PMC article.

103

Cercospora sp. as a source of anti-aging polyketides targeting 26S proteasome and scale-up production in submerged bioreactor.

Georgousaki K, Tsafantakis N, Gumeni S, González-Menéndez V, de Pedro N, Tormo JR, Almeida C, Lambert C, Genilloud O, Trougakos IP, Fokialakis N. Georgousaki K, et al. Among authors: trougakos ip. J Biotechnol. 2019 Aug 10;301:88-96. doi: 10.1016/j.jbiotec.2019.05.015. Epub 2019 May 29. J Biotechnol. 2019. PMID: 31152756

104

Functional wiring of proteostatic and mitostatic modules ensures transient organismal survival during imbalanced mitochondrial dynamics.

Gumeni S, Evangelakou Z, Tsakiri EN, Scorrano L, Trougakos IP. Gumeni S, et al. Among authors: trougakos ip. Redox Biol. 2019 Jun;24:101219. doi: 10.1016/j.redox.2019.101219. Epub 2019 May 17. Redox Biol. 2019. PMID: 31132524 Free PMC article.

105

Terrestrial Microorganisms: Cell Factories of Bioactive Molecules with Skin Protecting Applications.

Peyrat LA, Tsafantakis N, Georgousaki K, Ouazzani J, Genilloud O, Trougakos IP, Fokialakis N. Peyrat LA, et al. Among authors: trougakos ip. Molecules. 2019 May 13;24(9):1836. doi: 10.3390/molecules24091836. Molecules. 2019. PMID: 31086077 Free PMC article. Review.

106

Nutrigenomics as a tool to study the impact of diet on aging and age-related diseases: the Drosophila approach.

Evangelakou Z, Manola M, Gumeni S, Trougakos IP. Evangelakou Z, et al. Among authors: trougakos ip. Genes Nutr. 2019 May 2;14:12. doi: 10.1186/s12263-019-0638-6. eCollection 2019. Genes Nutr. 2019. PMID: 31073342 Free PMC article. Review.

107

Proteasome dysfunction induces excessive proteome instability and loss of mitostasis that can be mitigated by enhancing mitochondrial fusion or autophagy.

Tsakiri EN, Gumeni S, Vougas K, Pendin D, Papassideri I, Daga A, Gorgoulis V, Juhász G, Scorrano L, Trougakos IP. Tsakiri EN, et al. Among authors: trougakos ip. Autophagy. 2019 Oct;15(10):1757-1773. doi: 10.1080/15548627.2019.1596477. Epub 2019 Apr 19. Autophagy. 2019. PMID: 31002009 Free PMC article.

108

Toll-Like Receptor 4 Activation Promotes Multiple Myeloma Cell Growth and Survival Via Suppression of The Endoplasmic Reticulum Stress Factor Chop.

Bagratuni T, Sklirou AD, Kastritis E, Liacos CI, Spilioti C, Eleutherakis-Papaiakovou E, Kanellias N, Gavriatopoulou M, Terpos E, Trougakos IP, Dimopoulos MA. Bagratuni T, et al. Among authors: trougakos ip. Sci Rep. 2019 Mar 1;9(1):3245. doi: 10.1038/s41598-019-39672-7. Sci Rep. 2019. PMID: 30824741 Free PMC article.

109

Comparison survey of EVOO polyphenols and exploration of healthy aging-promoting properties of oleocanthal and oleacein.

Nikou T, Liaki V, Stathopoulos P, Sklirou AD, Tsakiri EN, Jakschitz T, Bonn G, Trougakos IP, Halabalaki M, Skaltsounis LA. Nikou T, et al. Among authors: trougakos ip. Food Chem Toxicol. 2019 Mar;125:403-412. doi: 10.1016/j.fct.2019.01.016. Epub 2019 Jan 21. Food Chem Toxicol. 2019. PMID: 30677444

110

Consolidation therapy with the combination of bortezomib and lenalidomide (VR) without dexamethasone in multiple myeloma patients after transplant: Effects on survival and bone outcomes in the absence of bisphosphonates.

Terpos E, Kastritis E, Ntanasis-Stathopoulos I, Christoulas D, Papatheodorou A, Eleutherakis-Papaiakovou E, Kanellias N, Fotiou D, Ziogas DC, Migkou M, Roussou M, Trougakos IP, Gavriatopoulou M, Dimopoulos MA. Terpos E, et al. Among authors: trougakos ip. Am J Hematol. 2019 Apr;94(4):400-407. doi: 10.1002/ajh.25392. Epub 2019 Jan 10. Am J Hematol. 2019. PMID: 30592079 Free article. Clinical Trial.

111

Hyperactivation of Nrf2 increases stress tolerance at the cost of aging acceleration due to metabolic deregulation.

Tsakiri EN, Gumeni S, Iliaki KK, Benaki D, Vougas K, Sykiotis GP, Gorgoulis VG, Mikros E, Scorrano L, Trougakos IP. Tsakiri EN, et al. Among authors: trougakos ip. Aging Cell. 2019 Feb;18(1):e12845. doi: 10.1111/acel.12845. Epub 2018 Dec 10. Aging Cell. 2019. PMID: 30537423 Free PMC article.

112

Molecular mechanisms of carfilzomib-induced cardiotoxicity in mice and the emerging cardioprotective role of metformin.

Efentakis P, Kremastiotis G, Varela A, Nikolaou PE, Papanagnou ED, Davos CH, Tsoumani M, Agrogiannis G, Konstantinidou A, Kastritis E, Kanaki Z, Iliodromitis EK, Klinakis A, Dimopoulos MA, Trougakos IP, Andreadou I, Terpos E. Efentakis P, et al. Among authors: trougakos ip. Blood. 2019 Feb 14;133(7):710-723. doi: 10.1182/blood-2018-06-858415. Epub 2018 Nov 27. Blood. 2019. PMID: 30482794 Free article.

113

Chios mastic improves blood pressure haemodynamics in patients with arterial hypertension: Implications for regulation of proteostatic pathways.

Kontogiannis C, Georgiopoulos G, Loukas K, Papanagnou ED, Pachi VK, Bakogianni I, Laina A, Kouzoupis A, Karatzi K, Trougakos IP, Stamatelopoulos K. Kontogiannis C, et al. Among authors: trougakos ip. Eur J Prev Cardiol. 2019 Feb;26(3):328-331. doi: 10.1177/2047487318796985. Epub 2018 Aug 30. Eur J Prev Cardiol. 2019. PMID: 30160513 Clinical Trial. No abstract available.

114

Phytochemical Composition of the Decoctions of Greek Edible Greens (Chórta) and Evaluation of Antioxidant and Cytotoxic Properties.

Mikropoulou EV, Vougogiannopoulou K, Kalpoutzakis E, Sklirou AD, Skaperda Z, Houriet J, Wolfender JL, Trougakos IP, Kouretas D, Halabalaki M, Mitakou S. Mikropoulou EV, et al. Among authors: trougakos ip. Molecules. 2018 Jun 26;23(7):1541. doi: 10.3390/molecules23071541. Molecules. 2018. PMID: 29949914 Free PMC article.

115

Evaluation of minimal residual disease using next-generation flow cytometry in patients with AL amyloidosis.

Kastritis E, Kostopoulos IV, Terpos E, Paiva B, Fotiou D, Gavriatopoulou M, Kanellias N, Ziogas DC, Roussou M, Migkou M, Eleutherakis-Papaiakovou E, Trougakos IP, Tsitsilonis O, Dimopoulos MA. Kastritis E, et al. Among authors: trougakos ip. Blood Cancer J. 2018 May 24;8(5):46. doi: 10.1038/s41408-018-0086-3. Blood Cancer J. 2018. PMID: 29795385 Free PMC article. No abstract available.

116

Targeting Protein Quality Control Mechanisms by Natural Products to Promote Healthy Ageing.

Wedel S, Manola M, Cavinato M, Trougakos IP, Jansen-Dürr P. Wedel S, et al. Among authors: trougakos ip. Molecules. 2018 May 19;23(5):1219. doi: 10.3390/molecules23051219. Molecules. 2018. PMID: 29783751 Free PMC article. Review.

117

Integrating the DNA damage and protein stress responses during cancer development and treatment.

Gorgoulis VG, Pefani DE, Pateras IS, Trougakos IP. Gorgoulis VG, et al. Among authors: trougakos ip. J Pathol. 2018 Sep;246(1):12-40. doi: 10.1002/path.5097. Epub 2018 Jul 19. J Pathol. 2018. PMID: 29756349 Free PMC article. Review.

118

Ziros PG, Habeos IG, Chartoumpekis DV, Ntalampyra E, Somm E, Renaud CO, Bongiovanni M, Trougakos IP, Yamamoto M, Kensler TW, Santisteban P, Carrasco N, Ris-Stalpers C, Amendola E, Liao XH, Rossich L, Thomasz L, Juvenal GJ, Refetoff S, Sykiotis GP. Ziros PG, et al. Among authors: trougakos ip. Thyroid. 2018 Jun;28(6):780-798. doi: 10.1089/thy.2018.0018. Thyroid. 2018. PMID: 29742982 Free PMC article.

119

Novel Natural Products for Healthy Ageing from the Mediterranean Diet and Food Plants of Other Global Sources-The MediHealth Project.

Waltenberger B, Halabalaki M, Schwaiger S, Adamopoulos N, Allouche N, Fiebich BL, Hermans N, Jansen-Dürr P, Kesternich V, Pieters L, Schönbichler S, Skaltsounis AL, Tran H, Trougakos IP, Viljoen A, Wolfender JL, Wolfrum C, Xynos N, Stuppner H. Waltenberger B, et al. Among authors: trougakos ip. Molecules. 2018 May 6;23(5):1097. doi: 10.3390/molecules23051097. Molecules. 2018. PMID: 29734769 Free PMC article.

120

Molecular responses to therapeutic proteasome inhibitors in multiple myeloma patients are donor-, cell type- and drug-dependent.

Papanagnou ED, Terpos E, Kastritis E, Papassideri IS, Tsitsilonis OE, Dimopoulos MA, Trougakos IP. Papanagnou ED, et al. Among authors: trougakos ip. Oncotarget. 2018 Apr 3;9(25):17797-17809. doi: 10.18632/oncotarget.24882. eCollection 2018 Apr 3. Oncotarget. 2018. PMID: 29707147 Free PMC article.

121

Selective cytotoxicity of the herbal substance acteoside against tumor cells and its mechanistic insights.

Cheimonidi C, Samara P, Polychronopoulos P, Tsakiri EN, Nikou T, Myrianthopoulos V, Sakellaropoulos T, Zoumpourlis V, Mikros E, Papassideri I, Argyropoulou A, Halabalaki M, Alexopoulos LG, Skaltsounis AL, Tsitsilonis OE, Aligiannis NN, Trougakos IP. Cheimonidi C, et al. Among authors: trougakos ip. Redox Biol. 2018 Jun;16:169-178. doi: 10.1016/j.redox.2018.02.015. Epub 2018 Mar 1. Redox Biol. 2018. PMID: 29505920 Free PMC article.

122

A prototypical non-malignant epithelial model to study genome dynamics and concurrently monitor micro-RNAs and proteins in situ during oncogene-induced senescence.

Komseli ES, Pateras IS, Krejsgaard T, Stawiski K, Rizou SV, Polyzos A, Roumelioti FM, Chiourea M, Mourkioti I, Paparouna E, Zampetidis CP, Gumeni S, Trougakos IP, Pefani DE, O'Neill E, Gagos S, Eliopoulos AG, Fendler W, Chowdhury D, Bartek J, Gorgoulis VG. Komseli ES, et al. Among authors: trougakos ip. BMC Genomics. 2018 Jan 10;19(1):37. doi: 10.1186/s12864-017-4375-1. BMC Genomics. 2018. PMID: 29321003 Free PMC article.

123

Milder degenerative effects of Carfilzomib vs. Bortezomib in the Drosophila model: a link to clinical adverse events.

Tsakiri EN, Terpos E, Papanagnou ED, Kastritis E, Brieudes V, Halabalaki M, Bagratuni T, Florea BI, Overkleeft HS, Scorrano L, Skaltsounis AL, Dimopoulos MA, Trougakos IP. Tsakiri EN, et al. Among authors: trougakos ip. Sci Rep. 2017 Dec 19;7(1):17802. doi: 10.1038/s41598-017-17596-4. Sci Rep. 2017. PMID: 29259189 Free PMC article.

124

Cancer chemoprevention via activation of proteostatic modules.

Sklirou A, Papanagnou ED, Fokialakis N, Trougakos IP. Sklirou A, et al. Among authors: trougakos ip. Cancer Lett. 2018 Jan 28;413:110-121. doi: 10.1016/j.canlet.2017.10.034. Epub 2017 Oct 26. Cancer Lett. 2018. PMID: 29107114 Review.

125

Proteome Stability as a Key Factor of Genome Integrity.

Gumeni S, Evangelakou Z, Gorgoulis VG, Trougakos IP. Gumeni S, et al. Among authors: trougakos ip. Int J Mol Sci. 2017 Sep 22;18(10):2036. doi: 10.3390/ijms18102036. Int J Mol Sci. 2017. PMID: 28937603 Free PMC article. Review.

126

6-bromo-indirubin-3'-oxime (6BIO), a Glycogen synthase kinase-3β inhibitor, activates cytoprotective cellular modules and suppresses cellular senescence-mediated biomolecular damage in human fibroblasts.

Sklirou AD, Gaboriaud-Kolar N, Papassideri I, Skaltsounis AL, Trougakos IP. Sklirou AD, et al. Among authors: trougakos ip. Sci Rep. 2017 Sep 15;7(1):11713. doi: 10.1038/s41598-017-11662-7. Sci Rep. 2017. PMID: 28916781 Free PMC article.

127

Isolation of natural products with anti-ageing activity from the fruits of Platanus orientalis.

Chatzigeorgiou S, Thai QD, Tchoumtchoua J, Tallas K, Tsakiri EN, Papassideri I, Halabalaki M, Skaltsounis AL, Trougakos IP. Chatzigeorgiou S, et al. Among authors: trougakos ip. Phytomedicine. 2017 Sep 15;33:53-61. doi: 10.1016/j.phymed.2017.07.009. Epub 2017 Jul 31. Phytomedicine. 2017. PMID: 28887920

128

The unexpected function of a highly conserved YXXΦ motif in HCV core protein.

Karamichali E, Serti E, Gianneli A, Papaefthymiou A, Kakkanas A, Foka P, Seremetakis A, Katsarou K, Trougakos IP, Georgopoulou U. Karamichali E, et al. Among authors: trougakos ip. Infect Genet Evol. 2017 Oct;54:251-262. doi: 10.1016/j.meegid.2017.07.001. Epub 2017 Jul 5. Infect Genet Evol. 2017. PMID: 28687362

129

Anti-Melanogenic Properties of Greek Plants. A Novel Depigmenting Agent from Morus alba Wood.

Chaita E, Lambrinidis G, Cheimonidi C, Agalou A, Beis D, Trougakos I, Mikros E, Skaltsounis AL, Aligiannis N. Chaita E, et al. Among authors: trougakos i. Molecules. 2017 Mar 23;22(4):514. doi: 10.3390/molecules22040514. Molecules. 2017. PMID: 28333105 Free PMC article.

130

Erratum to 'Exploring and exploiting the systemic effects of deregulated replication licensing' [Seminars in Cancer Biology 37-38C, (2016) 3-15].

Petrakis TG, Komseli ES, Papaioannou M, Vougas K, Polyzos A, Myrianthopoulos V, Mikros E, Trougakos IP, Thanos D, Branzei D, Townsend P, Gorgoulis VG. Petrakis TG, et al. Among authors: trougakos ip. Semin Cancer Biol. 2017 Apr;43:180. doi: 10.1016/j.semcancer.2017.02.002. Epub 2017 Feb 21. Semin Cancer Biol. 2017. PMID: 28254408 No abstract available.

131

The Indirubin Derivative 6-Bromoindirubin-3'-Oxime Activates Proteostatic Modules, Reprograms Cellular Bioenergetic Pathways, and Exerts Antiaging Effects.

Tsakiri EN, Gaboriaud-Kolar N, Iliaki KK, Tchoumtchoua J, Papanagnou ED, Chatzigeorgiou S, Tallas KD, Mikros E, Halabalaki M, Skaltsounis AL, Trougakos IP. Tsakiri EN, et al. Among authors: trougakos ip. Antioxid Redox Signal. 2017 Nov 10;27(14):1027-1047. doi: 10.1089/ars.2016.6910. Epub 2017 May 16. Antioxid Redox Signal. 2017. PMID: 28253732 Free PMC article.

132

Redox Status and Proteostasis in Ageing and Disease.

Rizzi F, Trougakos IP, Pintus G, Sykiotis GP. Rizzi F, et al. Among authors: trougakos ip. Oxid Med Cell Longev. 2016;2016:7476241. doi: 10.1155/2016/7476241. Epub 2016 Feb 22. Oxid Med Cell Longev. 2016. PMID: 26998195 Free PMC article. No abstract available.

133

Cross Talk of Proteostasis and Mitostasis in Cellular Homeodynamics, Ageing, and Disease.

Gumeni S, Trougakos IP. Gumeni S, et al. Among authors: trougakos ip. Oxid Med Cell Longev. 2016;2016:4587691. doi: 10.1155/2016/4587691. Epub 2016 Feb 9. Oxid Med Cell Longev. 2016. PMID: 26977249 Free PMC article. Review.

134

Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition).

Klionsky DJ, Abdelmohsen K, Abe A, Abedin MJ, Abeliovich H, Acevedo Arozena A, Adachi H, Adams CM, Adams PD, Adeli K, Adhihetty PJ, Adler SG, Agam G, Agarwal R, Aghi MK, Agnello M, Agostinis P, Aguilar PV, Aguirre-Ghiso J, Airoldi EM, Ait-Si-Ali S, Akematsu T, Akporiaye ET, Al-Rubeai M, Albaiceta GM, Albanese C, Albani D, Albert ML, Aldudo J, Algül H, Alirezaei M, Alloza I, Almasan A, Almonte-Beceril M, Alnemri ES, Alonso C, Altan-Bonnet N, Altieri DC, Alvarez S, Alvarez-Erviti L, Alves S, Amadoro G, Amano A, Amantini C, Ambrosio S, Amelio I, Amer AO, Amessou M, Amon A, An Z, Anania FA, Andersen SU, Andley UP, Andreadi CK, Andrieu-Abadie N, Anel A, Ann DK, Anoopkumar-Dukie S, Antonioli M, Aoki H, Apostolova N, Aquila S, Aquilano K, Araki K, Arama E, Aranda A, Araya J, Arcaro A, Arias E, Arimoto H, Ariosa AR, Armstrong JL, Arnould T, Arsov I, Asanuma K, Askanas V, Asselin E, Atarashi R, Atherton SS, Atkin JD, Attardi LD, Auberger P, Auburger G, Aurelian L, Autelli R, Avagliano L, Avantaggiati ML, Avrahami L, Awale S, Azad N, Bachetti T, Backer JM, Bae DH, Bae JS, Bae ON, Bae SH, Baehrecke EH, Baek SH, Baghdiguian S, Bagniewska-Zadworna A, Bai H, Bai J, Bai XY, Bailly Y, Balaji KN, … See abstract for full author list ➔ Klionsky DJ, et al. Among authors: trougakos ip. Autophagy. 2016;12(1):1-222. doi: 10.1080/15548627.2015.1100356. Autophagy. 2016. PMID: 26799652 Free PMC article. No abstract available.

135

Exploring and exploiting the systemic effects of deregulated replication licensing.

Petrakis TG, Komseli ES, Papaioannou M, Vougas K, Polyzos A, Myrianthopoulos V, Mikros E, Trougakos IP, Thanos D, Branzei D, Townsend P, Gorgoulis VG. Petrakis TG, et al. Among authors: trougakos ip. Semin Cancer Biol. 2016 Jun;37-38:3-15. doi: 10.1016/j.semcancer.2015.12.002. Epub 2015 Dec 17. Semin Cancer Biol. 2016. PMID: 26707000 Review.

136

Progression of mouse skin carcinogenesis is associated with the orchestrated deregulation of mir-200 family members, mir-205 and their common targets.

Skourti E, Logotheti S, Kontos CK, Pavlopoulou A, Dimoragka PT, Trougakos IP, Gorgoulis V, Scorilas A, Michalopoulos I, Zoumpourlis V. Skourti E, et al. Among authors: trougakos ip. Mol Carcinog. 2016 Aug;55(8):1229-42. doi: 10.1002/mc.22365. Epub 2015 Aug 27. Mol Carcinog. 2016. PMID: 26527515

137

Comparative Meta-Analysis of Transcriptomics Data during Cellular Senescence and In Vivo Tissue Ageing.

Voutetakis K, Chatziioannou A, Gonos ES, Trougakos IP. Voutetakis K, et al. Among authors: trougakos ip. Oxid Med Cell Longev. 2015;2015:732914. doi: 10.1155/2015/732914. Epub 2015 Apr 21. Oxid Med Cell Longev. 2015. PMID: 25977747 Free PMC article.

138

Hexapeptide-11 is a novel modulator of the proteostasis network in human diploid fibroblasts.

Sklirou AD, Ralli M, Dominguez M, Papassideri I, Skaltsounis AL, Trougakos IP. Sklirou AD, et al. Among authors: trougakos ip. Redox Biol. 2015 Aug;5:205-215. doi: 10.1016/j.redox.2015.04.010. Epub 2015 Apr 29. Redox Biol. 2015. PMID: 25974626 Free PMC article.

139

Structural studies and cytotoxicity assays of "aggregation-prone" IAPP(8-16) and its non-amyloidogenic variants suggest its important role in fibrillogenesis and cytotoxicity of human amylin.

Louros NN, Tsiolaki PL, Zompra AA, Pappa EV, Magafa V, Pairas G, Cordopatis P, Cheimonidou C, Trougakos IP, Iconomidou VA, Hamodrakas SJ. Louros NN, et al. Among authors: trougakos ip. Biopolymers. 2015 May;104(3):196-205. doi: 10.1002/bip.22650. Biopolymers. 2015. PMID: 25913357

140

The amazing ubiquitin-proteasome system: structural components and implication in aging.

Tsakiri EN, Trougakos IP. Tsakiri EN, et al. Among authors: trougakos ip. Int Rev Cell Mol Biol. 2015;314:171-237. doi: 10.1016/bs.ircmb.2014.09.002. Epub 2014 Nov 18. Int Rev Cell Mol Biol. 2015. PMID: 25619718 Review.

141

Molecular chaperones and proteostasis regulation during redox imbalance.

Niforou K, Cheimonidou C, Trougakos IP. Niforou K, et al. Among authors: trougakos ip. Redox Biol. 2014 Jan 30;2:323-32. doi: 10.1016/j.redox.2014.01.017. eCollection 2014. Redox Biol. 2014. PMID: 24563850 Free PMC article. Review.

142

Natural compounds with anti-ageing activity.

Argyropoulou A, Aligiannis N, Trougakos IP, Skaltsounis AL. Argyropoulou A, et al. Among authors: trougakos ip. Nat Prod Rep. 2013 Oct 11;30(11):1412-37. doi: 10.1039/c3np70031c. Nat Prod Rep. 2013. PMID: 24056714 Review.

143

Prothymosin α and a prothymosin α-derived peptide enhance T(H)1-type immune responses against defined HER-2/neu epitopes.

Ioannou K, Derhovanessian E, Tsakiri E, Samara P, Kalbacher H, Voelter W, Trougakos IP, Pawelec G, Tsitsilonis OE. Ioannou K, et al. Among authors: trougakos ip. BMC Immunol. 2013 Sep 22;14:43. doi: 10.1186/1471-2172-14-43. BMC Immunol. 2013. PMID: 24053720 Free PMC article.

144

Diet-derived advanced glycation end products or lipofuscin disrupts proteostasis and reduces life span in Drosophila melanogaster.

Tsakiri EN, Iliaki KK, Höhn A, Grimm S, Papassideri IS, Grune T, Trougakos IP. Tsakiri EN, et al. Among authors: trougakos ip. Free Radic Biol Med. 2013 Dec;65:1155-1163. doi: 10.1016/j.freeradbiomed.2013.08.186. Epub 2013 Aug 30. Free Radic Biol Med. 2013. PMID: 23999505

145

The DNA damage checkpoint precedes activation of ARF in response to escalating oncogenic stress during tumorigenesis.

Evangelou K, Bartkova J, Kotsinas A, Pateras IS, Liontos M, Velimezi G, Kosar M, Liloglou T, Trougakos IP, Dyrskjot L, Andersen CL, Papaioannou M, Drosos Y, Papafotiou G, Hodny Z, Sosa-Pineda B, Wu XR, Klinakis A, Ørntoft T, Lukas J, Bartek J, Gorgoulis VG. Evangelou K, et al. Among authors: trougakos ip. Cell Death Differ. 2013 Nov;20(11):1485-97. doi: 10.1038/cdd.2013.76. Epub 2013 Jul 12. Cell Death Differ. 2013. PMID: 23852374 Free PMC article.

146

Proteasome dysfunction in Drosophila signals to an Nrf2-dependent regulatory circuit aiming to restore proteostasis and prevent premature aging.

Tsakiri EN, Sykiotis GP, Papassideri IS, Terpos E, Dimopoulos MA, Gorgoulis VG, Bohmann D, Trougakos IP. Tsakiri EN, et al. Among authors: trougakos ip. Aging Cell. 2013 Oct;12(5):802-13. doi: 10.1111/acel.12111. Epub 2013 Jun 28. Aging Cell. 2013. PMID: 23738891 Free PMC article.

147

Molecular effects of advanced glycation end products on cell signalling pathways, ageing and pathophysiology.

Nedić O, Rattan SI, Grune T, Trougakos IP. Nedić O, et al. Among authors: trougakos ip. Free Radic Res. 2013 Aug;47 Suppl 1:28-38. doi: 10.3109/10715762.2013.806798. Free Radic Res. 2013. PMID: 23692178 Review.

148

The molecular chaperone apolipoprotein J/clusterin as a sensor of oxidative stress: implications in therapeutic approaches - a mini-review.

Trougakos IP. Trougakos IP. Gerontology. 2013;59(6):514-23. doi: 10.1159/000351207. Epub 2013 May 15. Gerontology. 2013. PMID: 23689375 Free article. Review.

149

Non-enzymatic post-translational protein modifications and proteostasis network deregulation in carcinogenesis.

Trougakos IP, Sesti F, Tsakiri E, Gorgoulis VG. Trougakos IP, et al. J Proteomics. 2013 Oct 30;92:274-98. doi: 10.1016/j.jprot.2013.02.024. Epub 2013 Mar 14. J Proteomics. 2013. PMID: 23500136 Review.

150

Differential regulation of proteasome functionality in reproductive vs. somatic tissues of Drosophila during aging or oxidative stress.

Tsakiri EN, Sykiotis GP, Papassideri IS, Gorgoulis VG, Bohmann D, Trougakos IP. Tsakiri EN, et al. Among authors: trougakos ip. FASEB J. 2013 Jun;27(6):2407-20. doi: 10.1096/fj.12-221408. Epub 2013 Mar 1. FASEB J. 2013. PMID: 23457214 Free PMC article.

151

Specific lipofuscin staining as a novel biomarker to detect replicative and stress-induced senescence. A method applicable in cryo-preserved and archival tissues.

Georgakopoulou EA, Tsimaratou K, Evangelou K, Fernandez Marcos PJ, Zoumpourlis V, Trougakos IP, Kletsas D, Bartek J, Serrano M, Gorgoulis VG. Georgakopoulou EA, et al. Among authors: trougakos ip. Aging (Albany NY). 2013 Jan;5(1):37-50. doi: 10.18632/aging.100527. Aging (Albany NY). 2013. PMID: 23449538 Free PMC article.

152

Oxidative stress-mediated biomolecular damage and inflammation in tumorigenesis.

Sesti F, Tsitsilonis OE, Kotsinas A, Trougakos IP. Sesti F, et al. Among authors: trougakos ip. In Vivo. 2012 May-Jun;26(3):395-402. In Vivo. 2012. PMID: 22523291 Review.

153

Cdc6 expression represses E-cadherin transcription and activates adjacent replication origins.

Sideridou M, Zakopoulou R, Evangelou K, Liontos M, Kotsinas A, Rampakakis E, Gagos S, Kahata K, Grabusic K, Gkouskou K, Trougakos IP, Kolettas E, Georgakilas AG, Volarevic S, Eliopoulos AG, Zannis-Hadjopoulos M, Moustakas A, Gorgoulis VG. Sideridou M, et al. Among authors: trougakos ip. J Cell Biol. 2011 Dec 26;195(7):1123-40. doi: 10.1083/jcb.201108121. J Cell Biol. 2011. PMID: 22201124 Free PMC article.

154

Apolipoprotein J/clusterin in human erythrocytes is involved in the molecular process of defected material disposal during vesiculation.

Antonelou MH, Kriebardis AG, Stamoulis KE, Trougakos IP, Papassideri IS. Antonelou MH, et al. Among authors: trougakos ip. PLoS One. 2011;6(10):e26033. doi: 10.1371/journal.pone.0026033. Epub 2011 Oct 7. PLoS One. 2011. PMID: 22016805 Free PMC article.

155

Apolipoprotein J/Clusterin is a novel structural component of human erythrocytes and a biomarker of cellular stress and senescence.

Antonelou MH, Kriebardis AG, Stamoulis KE, Trougakos IP, Papassideri IS. Antonelou MH, et al. Among authors: trougakos ip. PLoS One. 2011;6(10):e26032. doi: 10.1371/journal.pone.0026032. Epub 2011 Oct 6. PLoS One. 2011. PMID: 21998749 Free PMC article.

156

CRM1 protein-mediated regulation of nuclear clusterin (nCLU), an ionizing radiation-stimulated, Bax-dependent pro-death factor.

Leskov KS, Araki S, Lavik JP, Gomez JA, Gama V, Gonos ES, Trougakos IP, Matsuyama S, Boothman DA. Leskov KS, et al. Among authors: trougakos ip. J Biol Chem. 2011 Nov 18;286(46):40083-90. doi: 10.1074/jbc.M111.252957. Epub 2011 Sep 27. J Biol Chem. 2011. PMID: 21953454 Free PMC article.

157

Increased expression levels of apolipoprotein J/clusterin during primary osteoarthritis.

Fandridis E, Apergis G, Korres DS, Nikolopoulos K, Zoubos AB, Papassideri I, Trougakos IP. Fandridis E, et al. Among authors: trougakos ip. In Vivo. 2011 Sep-Oct;25(5):745-9. In Vivo. 2011. PMID: 21753128

158

Design, synthesis and antiproliferative activity of novel aminosubstituted benzothiopyranoisoindoles.

Christodoulou A, Kostakis IK, Kourafalos V, Pouli N, Marakos P, Trougakos IP, Tsitsilonis OE. Christodoulou A, et al. Among authors: trougakos ip. Bioorg Med Chem Lett. 2011 May 15;21(10):3110-2. doi: 10.1016/j.bmcl.2011.03.021. Epub 2011 Mar 11. Bioorg Med Chem Lett. 2011. PMID: 21444205

159

Induction of clusterin by AKT--role in cytoprotection against docetaxel in prostate tumor cells.

Zhong B, Sallman DA, Gilvary DL, Pernazza D, Sahakian E, Fritz D, Cheng JQ, Trougakos I, Wei S, Djeu JY. Zhong B, et al. Among authors: trougakos i. Mol Cancer Ther. 2010 Jun;9(6):1831-41. doi: 10.1158/1535-7163.MCT-09-0880. Epub 2010 May 25. Mol Cancer Ther. 2010. PMID: 20501799 Free PMC article.

160

Genome-wide transcriptome profile of the human osteosarcoma Sa OS and U-2 OS cell lines.

Trougakos IP, Chondrogianni N, Amarantos I, Blake J, Schwager C, Wirkner U, Ansorge W, Gonos ES. Trougakos IP, et al. Cancer Genet Cytogenet. 2010 Jan 15;196(2):109-18. doi: 10.1016/j.cancergencyto.2009.09.012. Cancer Genet Cytogenet. 2010. PMID: 20082845

161

Chapter 9: Oxidative stress in malignant progression: The role of Clusterin, a sensitive cellular biosensor of free radicals.

Trougakos IP, Gonos ES. Trougakos IP, et al. Adv Cancer Res. 2009;104:171-210. doi: 10.1016/S0065-230X(09)04009-3. Adv Cancer Res. 2009. PMID: 19878777 Review.

162

Vanadium-induced apoptosis of HaCaT cells is mediated by c-fos and involves nuclear accumulation of clusterin.

Markopoulou S, Kontargiris E, Batsi C, Tzavaras T, Trougakos I, Boothman DA, Gonos ES, Kolettas E. Markopoulou S, et al. Among authors: trougakos i. FEBS J. 2009 Jul;276(14):3784-99. doi: 10.1111/j.1742-4658.2009.07093.x. Epub 2009 Jun 15. FEBS J. 2009. PMID: 19531052 Free PMC article.

163

Transcriptional and posttranslational regulation of clusterin by the two main cellular proteolytic pathways.

Balantinou E, Trougakos IP, Chondrogianni N, Margaritis LH, Gonos ES. Balantinou E, et al. Among authors: trougakos ip. Free Radic Biol Med. 2009 May 1;46(9):1267-74. doi: 10.1016/j.freeradbiomed.2009.01.025. Free Radic Biol Med. 2009. PMID: 19353783

164

Advances and challenges in basic and translational research on clusterin.

Trougakos IP, Djeu JY, Gonos ES, Boothman DA. Trougakos IP, et al. Cancer Res. 2009 Jan 15;69(2):403-6. doi: 10.1158/0008-5472.CAN-08-2912. Cancer Res. 2009. PMID: 19147550 Free PMC article. No abstract available.

165

Intracellular clusterin inhibits mitochondrial apoptosis by suppressing p53-activating stress signals and stabilizing the cytosolic Ku70-Bax protein complex.

Trougakos IP, Lourda M, Antonelou MH, Kletsas D, Gorgoulis VG, Papassideri IS, Zou Y, Margaritis LH, Boothman DA, Gonos ES. Trougakos IP, et al. Clin Cancer Res. 2009 Jan 1;15(1):48-59. doi: 10.1158/1078-0432.CCR-08-1805. Clin Cancer Res. 2009. PMID: 19118032 Free PMC article.

166

Partial proteasome inhibition in human fibroblasts triggers accelerated M1 senescence or M2 crisis depending on p53 and Rb status.

Chondrogianni N, Trougakos IP, Kletsas D, Chen QM, Gonos ES. Chondrogianni N, et al. Among authors: trougakos ip. Aging Cell. 2008 Oct;7(5):717-32. doi: 10.1111/j.1474-9726.2008.00425.x. Epub 2008 Aug 1. Aging Cell. 2008. PMID: 18691182 Free article.

167

Biological monitoring of hexavalent chromium and serum levels of the senescence biomarker apolipoprotein J/Clusterin in welders.

Alexopoulos EC, Cominos X, Trougakos IP, Lourda M, Gonos ES, Makropoulos V. Alexopoulos EC, et al. Among authors: trougakos ip. Bioinorg Chem Appl. 2008;2008:420578. doi: 10.1155/2008/420578. Bioinorg Chem Appl. 2008. PMID: 18464919 Free PMC article.

168

Zinc, metallothioneins, and longevity--effect of zinc supplementation: zincage study.

Mocchegiani E, Giacconi R, Cipriano C, Costarelli L, Muti E, Tesei S, Giuli C, Papa R, Marcellini F, Mariani E, Rink L, Herbein G, Varin A, Fulop T, Monti D, Jajte J, Dedoussis G, Gonos ES, Trougakos IP, Malavolta M. Mocchegiani E, et al. Among authors: trougakos ip. Ann N Y Acad Sci. 2007 Nov;1119:129-46. doi: 10.1196/annals.1404.030. Ann N Y Acad Sci. 2007. PMID: 18056962 Review.

169

Exposure of human diploid fibroblasts to hypoxia extends proliferative life span.

Poulios E, Trougakos IP, Chondrogianni N, Gonos ES. Poulios E, et al. Among authors: trougakos ip. Ann N Y Acad Sci. 2007 Nov;1119:9-19. doi: 10.1196/annals.1404.025. Ann N Y Acad Sci. 2007. PMID: 18056950

170

Crystalline yolk spheroids in Drosophila melanogaster oocyte: freeze fracture and two-dimensional reconstruction analysis.

Papassideri IS, Trougakos IP, Leonard KR, Margaritis LH. Papassideri IS, et al. Among authors: trougakos ip. J Insect Physiol. 2007 Apr;53(4):370-6. doi: 10.1016/j.jinsphys.2006.12.011. Epub 2007 Jan 13. J Insect Physiol. 2007. PMID: 17292389

171

Development of resistance to chemotherapeutic drugs in human osteosarcoma cell lines largely depends on up-regulation of Clusterin/Apolipoprotein J.

Lourda M, Trougakos IP, Gonos ES. Lourda M, et al. Among authors: trougakos ip. Int J Cancer. 2007 Feb 1;120(3):611-22. doi: 10.1002/ijc.22327. Int J Cancer. 2007. PMID: 17096323 Free article.

172

Regulation of clusterin/apolipoprotein J, a functional homologue to the small heat shock proteins, by oxidative stress in ageing and age-related diseases.

Trougakos IP, Gonos ES. Trougakos IP, et al. Free Radic Res. 2006 Dec;40(12):1324-34. doi: 10.1080/10715760600902310. Free Radic Res. 2006. PMID: 17090421 Review.

173

Clusterin/Apolipoprotein J up-regulation after zinc exposure, replicative senescence or differentiation of human haematopoietic cells.

Trougakos IP, Pawelec G, Tzavelas C, Ntouroupi T, Gonos ES. Trougakos IP, et al. Biogerontology. 2006 Oct-Dec;7(5-6):375-82. doi: 10.1007/s10522-006-9052-8. Biogerontology. 2006. PMID: 16955214

174

Comparative effects of hypoxia on normal and immortalized human diploid fibroblasts.

Poulios E, Trougakos IP, Gonos ES. Poulios E, et al. Among authors: trougakos ip. Anticancer Res. 2006 May-Jun;26(3A):2165-8. Anticancer Res. 2006. PMID: 16827160 Free article.

175

Proteasome response to interferon-gamma is altered in senescent human fibroblasts.

Stratford FL, Chondrogianni N, Trougakos IP, Gonos ES, Rivett AJ. Stratford FL, et al. Among authors: trougakos ip. FEBS Lett. 2006 Jul 10;580(16):3989-94. doi: 10.1016/j.febslet.2006.06.029. Epub 2006 Jun 21. FEBS Lett. 2006. PMID: 16806194 Free article.

176

Reduced expression levels of the senescence biomarker clusterin/apolipoprotein j in lymphocytes from healthy centenarians.

Trougakos IP, Petropoulou C, Franceschi C, Gonos ES. Trougakos IP, et al. Ann N Y Acad Sci. 2006 May;1067:294-300. doi: 10.1196/annals.1354.039. Ann N Y Acad Sci. 2006. PMID: 16804001

177

Identification of differentially expressed proteins in senescent human embryonic fibroblasts.

Trougakos IP, Saridaki A, Panayotou G, Gonos ES. Trougakos IP, et al. Mech Ageing Dev. 2006 Jan;127(1):88-92. doi: 10.1016/j.mad.2005.08.009. Epub 2005 Oct 5. Mech Ageing Dev. 2006. PMID: 16213575

178

Glucocorticoid receptor isoforms in human hepatocarcinoma HepG2 and SaOS-2 osteosarcoma cells: presence of glucocorticoid receptor alpha in mitochondria and of glucocorticoid receptor beta in nucleoli.

Psarra AM, Solakidi S, Trougakos IP, Margaritis LH, Spyrou G, Sekeris CE. Psarra AM, et al. Among authors: trougakos ip. Int J Biochem Cell Biol. 2005 Dec;37(12):2544-58. doi: 10.1016/j.biocel.2005.06.015. Epub 2005 Jul 21. Int J Biochem Cell Biol. 2005. PMID: 16076561

179

Differential effects of clusterin/apolipoprotein J on cellular growth and survival.

Trougakos IP, Lourda M, Agiostratidou G, Kletsas D, Gonos ES. Trougakos IP, et al. Free Radic Biol Med. 2005 Feb 15;38(4):436-49. doi: 10.1016/j.freeradbiomed.2004.10.038. Free Radic Biol Med. 2005. PMID: 15649646

180

Ectopic expression of clusterin/apolipoprotein J or Bcl-2 decreases the sensitivity of HaCaT cells to toxic effects of ropivacaine.

Kontargiris E, Kolettas E, Vadalouca A, Trougakos IP, Gonos ES, Kalfakakou V. Kontargiris E, et al. Among authors: trougakos ip. Cell Res. 2004 Oct;14(5):415-22. doi: 10.1038/sj.cr.7290242. Cell Res. 2004. PMID: 15538973

181

Functional analysis of clusterin/apolipoprotein J in cellular death induced by severe genotoxic stress.

Trougakos IP, Gonos ES. Trougakos IP, et al. Ann N Y Acad Sci. 2004 Jun;1019:206-10. doi: 10.1196/annals.1297.033. Ann N Y Acad Sci. 2004. PMID: 15247015

182

Alterations of senescence biomarkers in human cells by exposure to CrVI in vivo and in vitro.

Katsiki M, Trougakos IP, Chondrogianni N, Alexopoulos EC, Makropoulos V, Gonos ES. Katsiki M, et al. Among authors: trougakos ip. Exp Gerontol. 2004 Jul;39(7):1079-87. doi: 10.1016/j.exger.2004.03.039. Exp Gerontol. 2004. PMID: 15236767

183

Phorbol myristate acetate induces changes on F-actin and vinculin content in immature rat Sertoli cells.

Kouloukoussa M, Aleporou-Marinou V, Angelopoulou B, Trougakos IP, Panagopoulou E, Kittas C, Marinos E. Kouloukoussa M, et al. Among authors: trougakos ip. Tissue Cell. 2004 Apr;36(2):149-55. doi: 10.1016/j.tice.2003.12.001. Tissue Cell. 2004. PMID: 15041417

184

Silencing expression of the clusterin/apolipoprotein j gene in human cancer cells using small interfering RNA induces spontaneous apoptosis, reduced growth ability, and cell sensitization to genotoxic and oxidative stress.

Trougakos IP, So A, Jansen B, Gleave ME, Gonos ES. Trougakos IP, et al. Cancer Res. 2004 Mar 1;64(5):1834-42. doi: 10.1158/0008-5472.can-03-2664. Cancer Res. 2004. PMID: 14996747

185

Structural and biochemical analysis of the Leptinotarsa decemlineata (Coleoptera; Chrysomeloidea) crystalline chorionic layer.

Papassideri IS, Trougakos IP, Leonard KR, Margaritis LH. Papassideri IS, et al. Among authors: trougakos ip. J Insect Physiol. 2003 Apr;49(4):377-84. doi: 10.1016/s0022-1910(03)00022-2. J Insect Physiol. 2003. PMID: 12769991

186

Central role of the proteasome in senescence and survival of human fibroblasts: induction of a senescence-like phenotype upon its inhibition and resistance to stress upon its activation.

Chondrogianni N, Stratford FL, Trougakos IP, Friguet B, Rivett AJ, Gonos ES. Chondrogianni N, et al. Among authors: trougakos ip. J Biol Chem. 2003 Jul 25;278(30):28026-37. doi: 10.1074/jbc.M301048200. Epub 2003 May 7. J Biol Chem. 2003. PMID: 12736271 Free article.

187

Serum levels of the senescence biomarker clusterin/apolipoprotein J increase significantly in diabetes type II and during development of coronary heart disease or at myocardial infarction.

Trougakos IP, Poulakou M, Stathatos M, Chalikia A, Melidonis A, Gonos ES. Trougakos IP, et al. Exp Gerontol. 2002 Oct-Nov;37(10-11):1175-87. doi: 10.1016/s0531-5565(02)00139-0. Exp Gerontol. 2002. PMID: 12470829

188

Clusterin/apolipoprotein J in human aging and cancer.

Trougakos IP, Gonos ES. Trougakos IP, et al. Int J Biochem Cell Biol. 2002 Nov;34(11):1430-48. doi: 10.1016/s1357-2725(02)00041-9. Int J Biochem Cell Biol. 2002. PMID: 12200037 Review.

189

Ageing research in Greece.

Gonos ES, Agrafiotis D, Dontas AS, Efthimiopoulos S, Galaris D, Karamanos NK, Kletsas D, Kolettas E, Panayotou G, Pratsinis H, Sekeri-Pataryas KE, Simoes D, Sourlingas TG, Stathakos D, Stratigos AJ, Tavernarakis N, Trougakos IP, Tsiganos CP, Vynios DH. Gonos ES, et al. Among authors: trougakos ip. Exp Gerontol. 2002 Jun;37(6):735-47. doi: 10.1016/s0531-5565(02)00017-7. Exp Gerontol. 2002. PMID: 12175474

190

Clusterin/apolipoprotein J is a novel biomarker of cellular senescence that does not affect the proliferative capacity of human diploid fibroblasts.

Petropoulou C, Trougakos IP, Kolettas E, Toussaint O, Gonos ES. Petropoulou C, et al. Among authors: trougakos ip. FEBS Lett. 2001 Dec 7;509(2):287-97. doi: 10.1016/s0014-5793(01)03150-7. FEBS Lett. 2001. PMID: 11741605 Free article.

191

Differential sorting of constitutively co-secreted proteins in the ovarian follicle cells of Drosophila.

Trougakos IP, Papassideri IS, Waring GL, Margaritis LH. Trougakos IP, et al. Eur J Cell Biol. 2001 Apr;80(4):271-84. doi: 10.1078/0171-9335-00163. Eur J Cell Biol. 2001. PMID: 11370742

192

Biochemical and immunocytochemical analysis of vitellogenesis in the olive fruit fly Dacus (bactrocera) oleae (Diptera: Tephritidae).

Trougakos IP, Lamnissou K, Margaritis LH. Trougakos IP, et al. Cell Biol Int. 1999;23(6):417-29. doi: 10.1006/cbir.1999.0380. Cell Biol Int. 1999. PMID: 10623421

193

The formation of the functional chorion structure of Drosophila virilis involves inercalation of the "middle" and "late" major chorion proteins: a general model for chorion assembly in Drosophilidae.

Trougakos IP, Margaritis LH. Trougakos IP, et al. J Struct Biol. 1998 Oct;123(2):97-110. doi: 10.1006/jsbi.1998.4999. J Struct Biol. 1998. PMID: 9917140

194

Immunolocalization of the temporally "early" secreted major structural chorion proteins, Dvs38 and Dvs36, in the eggshell layers and regions of Drosophila virilis.

Trougakos IP, Margaritis LH. Trougakos IP, et al. J Struct Biol. 1998 Oct;123(2):111-23. doi: 10.1006/jsbi.1998.4028. J Struct Biol. 1998. PMID: 9843665

195

Changing patterns of bacterial nosocomial infections: a nine-year study in a general hospital.

Maniatis AN, Trougakos IP, Katsanis G, Palermos J, Maniatis NA, Legakis NJ. Maniatis AN, et al. Among authors: trougakos ip. Chemotherapy. 1997 Jan-Feb;43(1):69-76. doi: 10.1159/000239538. Chemotherapy. 1997. PMID: 8996745

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

195 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

195 results

Results by year